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ABSTRACT
Regenerative therapy via stem cell transplantation has received increased attention to
help treat the myocardial injury associated with heart disease. Currently, the hybridisation
of SPECT with X-ray CT is expanding the utility of SPECT. This thesis compared two
SPECT/CT systems for attenuation correction using slow or fast-CT attenuation maps (µmaps).

We then developed a method to localize transplanted cells in relation to

compromised blood flow in the myocardium following a myocardial infarction using
SPECT/CT. Finally, a method to correct for image truncation was studied for a new
SPECT/CT design that incorporated small field-of-view (FOV) detectors.
Computer simulations compared gated-SPECT reconstructions using slow-CT and
fast-CT µ-maps with gated-CT µ-maps. Using fast-CT µ-maps improved the Root Mean
Squared (RMS) error from 4.2% to 4.0%. Three canine experiments were performed
comparing SPECT/CT reconstruction using the Infinia/Hawkeye-4 (slow-CT) and Symbia
T6 (fast-CT). Canines were euthanized prior to imaging, and then ventilated. The results
showed improvements in both RMS errors and correlation coefficients for all canines.
A first-pass contrast CT imaging technique can identify regions of myocardial
infarction and can be fused with SPECT. Ten canines underwent surgical ligation of the
left-anterior-descending artery. Cells were labeled with 111In-tropolone and transplanted
into the myocardium. SPECT/CT was performed on day of transplantation, 4, and 10 days
post-transplantation. For each imaging session first-pass perfusion CT was performed and
successfully delineated the infarct zone. Delayed-enhanced MRI was performed and
correlated well with first-pass CT. Contrast-to-noise ratios (CNR) were calculated for 111InSPECT and suggested that cells can be followed for 11 effective half-lives.
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We evaluated a modified SPECT/CT acquisition and reconstruction method for
truncated SPECT. Cardiac SPECT/CT scans were acquired in 14 patients. The original
projections were truncated to simulate a small FOV acquisition. Data was reconstructed in
three ways: non-truncated and standard reconstruction (NTOSEM), which was our goldstandard; truncated and standard reconstruction (TOSEM); and truncated and a modified
reconstruction (TMOSEM). Compared with NTOSEM, small FOV imaging incurred an
average cardiac count ratio error greater than 100% using TOSEM and 8.9% using
TMOSEM. When we plotted NTOSEM against TOSEM and TMOSEM the correlation
coefficient was 0.734 and 0.996 respectively.

Keywords: SPECT/CT, attenuation maps, slow-rotating CT, fast-rotating CT, stem cell
imaging, first-pass perfusion CT, cell localization, 111In labelling, contrast-to-noise ratio,
local tomography, cardiac imaging, projection truncation.
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CHAPTER 1:

GENERAL INTRODUCTION

1.1 INTRODUCTION
The World Health Organization estimates that by the year 2020 heart disease will
be the number one cause of disability [1]. Therefore, methods to diagnose and treat heart
disease will take on increasingly important roles in managing the health of the
population.
This thesis focuses on myocardial infarction, which is the destruction of heart
tissue resulting from obstruction or reduction of blood flow to the myocardium. Once
the myocardium is damaged the contracting muscle is replaced by fibrotic scar over a
period of months [2]. The self-healing or regenerative capacity of the heart is limited
compared with other organs, because of the small number of native cardiac stem cells,
making recovery from the infarction dependent upon medical intervention in the healing
process [3].
Current treatments for heart disease involve medications, surgery or a
combination or both. Patients with myocardial infarctions are currently treated acutely
with medications such as blood thinners to reduce the risk for a second event in the short
term; however, if blood flow remains compromised to the region of injury and there is
still viable heart muscle, balloon angioplasty or bypass surgery may improve heart
function and reduce the risk for another myocardial infarction [4]. In cases of extensive
injury with little to no hope for improvement in function a heart transplant may be
required. Unfortunately, transplant procedures have significant disadvantages including
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severity of surgery, a scarcity of donor hearts, transplant rejection, and the requirement
that the patient be on long term immunosuppressive therapy which increases the risk for
infections and cancer.
One potential alternative to heart transplantation that is receiving increased
attention over the past decade is regenerative therapy via stem cell transplantation [5].
The hope of this alternative is to restore the function of the original heart in situ in a
minimally invasive manner. In 2001, Orlic et al reported that the cardiac transplantation
of marrow-derived cells differentiated into cardiomyocytes and significantly reduced
myocardial fibrosis in a mouse model [6]. Although this study sparked great interest in
stem cell transplantation to help in myocardial regeneration, subsequent work in clinical
trials did not show the same level of improvement and gave mixed results [7, 8, 9]. It is
now clear that developing regenerative therapy is a very difficult undertaking that will
require scientific discovery on many fronts, from molecular biology to biomaterials and
imaging sciences. In addition, the optimum cell line to use, the route of administration of
the cells, the timing of the transplant in relationship to the infarct, and whether the
recipient tissue has been reperfused or is still subject to coronary occlusion still remains
to be determined. For medical imaging, techniques to visualize cell delivery, degree of
retention, and long-term survival are needed to help provide the answers to the above
questions [10, 11].
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1.2 IMAGING THE HEART FOR MONITORING STEM CELL THERAPY
Three popular modalities for cardiac imaging are: Magnetic Resonance Imaging
(MRI), Positron Emission Tomography (PET), and Single Photon Emission Computed
Tomography (SPECT). Cardiac applications on these modalities may require the use of
exogenous contrast agents to measure aspects of tissue or vascular properties; or – in the
case of cell therapies – the transplanted cells themselves.
A common contrast agent for MRI is Gadolinium-Diethylenetriamine Pentaacetic Acid (DTPA), which is marketed as Magnevist by Bayer Schering Pharma. Its
paramagnetic property, in a concentration dependent fashion, reduces the T1 relaxation
time (and to some extent the T2 and T2* relaxation times) in MRI, which is the source of
its clinical utility. A popular method of using Gd-DTPA is for delayed enhancement MRI
(DE-MRI) where the contrast agent is injected and allowed sufficient time
(approximately 10 minutes depending on the exact protocol) to accumulate in infarcted
regions, due to the breakdown in cellular membrane integrity, and then MR images are
acquired [12]. MRI currently provides the most accurate means of identifying infarct
extent and location [13].
In cell therapy applications, MRI may also be used to visualize specially-labeled
cells that have been transplanted into the heart. One class of cellular label that has
attracted considerable attention is nano-sized iron oxide particles, such as Super
Paramagnetic Iron Oxide nanoparticles that are incorporated into the transplanted cells.
MRI of transplanted iron oxide labeled cells has shown promise in several animal studies
[14, 15]. However, interesting challenges for this label include the lack of specificity for
intact, viable cells since the iron label from dead cells is taken up by macrophages that

4
are attracted as part of the inflammatory response to the infarction, and the dilution of the
label that occurs while cells are dividing [10, 16].
Positron Emission Tomography (PET) is in widespread use for cardiac
applications. Although perceived as expensive, it is currently enjoying tremendous
growth that has only been accelerated by the ongoing shortage of reactor-produced radioisotopes. Like MRI, PET too can image tissue properties and track labeled cells with the
use of

18

F-fluorodeoxyglucose (18F-FDG), but is limited by the short half-life (110

minutes) of the radioisotope and rapid clearance from labeled cells [17]. Recently, it has
been shown that cells may also be labeled with

64

Cu-Pysuvaldehyde-Bis(N4-

Methylthiosemicarbazone) (PTSM), allowing cells to be followed for longer periods of
time than with 18F-FDG. However, 64Cu is not readily available and its half-life of 13hours is still short for following cell lines over extended periods [18].
Single Photon Emission Computed Tomography (SPECT) is the most widely
used nuclear medicine modality.

Even with the availability of MRI and PET, the

majority of myocardial perfusion studies are performed with SPECT. Like MRI and
PET, SPECT can assess multiple parameters including the imaging of myocardial
perfusion and the visualization of labeled stem cells. In addition, SPECT is multispectral; therefore multiple parameters may be assessed simultaneously if different radionuclides can be assigned to each parameter. For example, a

99m

Tc labeled molecule is

typically used for perfusion imaging and allows inferring coronary obstruction to a
limited extent [19]; while, transplanted cells can be labeled with an
molecule [20]. Since

99m

Tc and

111

111

In labeled

In emit gamma rays of energies sufficiently different

to be discriminated by a gamma camera, they can be imaged simultaneously by SPECT.
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The radiotracer in wide-spread use for imaging cardiac blood flow is
labeled methoxyisobutyl isonitrile (MIBI) [21].

99m

Tc-

99m

Tc has a radioactive half-life of 6.02

hours and emits 140 keV gamma-rays. A popular protocol for MIBI SPECT involves
comparing coronary perfusion in a resting state to the stressed state to detect stressinduced myocardial blood flow deficits. This test is typically included in the initial
assessment of suspected ischemia, and as a prognostic indicator following infarction.
Rest/Stress imaging requires two radioisotope injections, each one followed by SPECT
imaging [19, 22]. The first injection takes place with the patient in a resting state, while
the second injection takes place with the patient in a stressed state. Stress can either be
induced by running on a treadmill to reach a certain specified heart rate (90% of
maximum heart rate), or via intravenous injection of the vasodilator dipyridamole which
induces coronary hyperemia, or the sympathomimetic drug dobutamine, which by
increasing myocardial oxygen demands, also induces a hyperemic response.
111

In-tropolone is used routinely to label white blood cells for imaging

inflammation [23]. The

111

In radionuclide has a radioactive half-life of 2.82 days and

emits gamma rays at both 173keV and 247keV. The relatively long half life of
makes it useful for tracking cells over days or even weeks [24].

111

111

In

In-tropolone labels

cells by first diffusing freely across the cell membrane. Once inside the cell, cytosolic
proteins bind the radiolabel, thus radiolabeling the cell from the inside.
In the end, the 99mTc SPECT image shows cardiac perfusion, and the 111In SPECT
the transplanted cells location within the heart and also their relationship to the area of
reduced perfusion. This information is potentially useful to evaluate the accuracy of
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transplantation, monitor the migration pattern of the cells, infer viability of the
transplanted cells, or monitor the size of the underlying infarct.

1.2.1 Radiation dose from 99mTc and 111In
Research has demonstrated that, in the process of labeling, the radiation dose per
cell cannot exceed certain levels depending on the type of cell since toxicity analysis has
shown that higher levels of radiation can cause cell death [25]. To determine the whole
body dose that one would receive from labeled cells transplanted in the myocardium, one
can use the typical dose of

111

In-tropolone for labeling white blood cells as part of a

clinically performed inflammation study as a comparison. Labeled white blood cells
would provide a whole body equivalent dose of 7mSv [26]. The whole body radiation
exposure dose for a patient undergoing a rest/stress protocol is approximately 12.5mSv
[26]. However, for stem cell labeling we would be using a tenth of the 111In dose to label
the cells reducing the whole body exposure dose to less than 1mSv.

1.3 SPECT DATA ACQUISITION
Data in SPECT are acquired using a Gamma Camera. A typical gamma camera
consists of a collimator, a scintillation crystal, photomultiplier tubes, and positioning
electronics. The role of the collimator is to act as a ‘lens’ for the imaging system by
rejecting gamma rays with undesirable trajectories. In the case of a parallel-hole
collimator, which was used in all of our experiments, the holes are parallel to each other
and perpendicular to the plane of imaging. This configuration passes only gamma rays
that are approximately perpendicular to the imaging plane and hence useful for image
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formation. The gamma rays that pass through the collimator impinge onto the
scintillation crystal, which converts them into light. Currently, the most popular choice of
scintillation crystal in SPECT is thallium-doped sodium iodide – NaI(Tl).

The

photomultiplier tubes convert the light from the scintillation crystal into an electrical
signal, via the photoelectric effect, and amplify the signal using a series of dynodes. The
amplified electrical signal is then passed through circuits that combine signals from
adjacent photomultiplier tubes to determine the position of the original gamma ray’s
interaction with the scintillation crystal. These locations are transferred to a computer
that tabulates successive gamma ray detection events into a two-dimensional array,
which is a projection of the radioactive distribution. In SPECT, these projections are
acquired at multiple angles around the patient. After data acquisition is complete, these
projections are used to reconstruct three-dimensional tomographic images of the original
distribution of radioisotope inside the patient.
Making SPECT quantitative is not straightforward. Three physical phenomena
that are central to interfering with quantitative SPECT are: photon attenuation, photon
scatter and distance-dependent resolution [27].
In an ideal SPECT imaging scenario all gamma rays emitted by the radioactively
decaying radionuclides would escape the body and be available for detection by a gamma
camera. In a realistic scenario, however, gamma rays pass through many layers of tissue
and often interact with that tissue prior to exiting the body. In this interaction, gammarays can be either absorbed photoelectrically, or scattered from their original trajectory
potentially away from the gamma camera [28]. Either way, they may not reach the
gamma camera. The amount and extent of attenuation is dependent on the gamma ray
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energy, the thickness of tissue the gamma ray has to pass through as well as the
composition of the tissue, since bone will attenuate more per unit path length than softer
tissues such as fat and muscle [29, 30].

Figure 1.1: Attenuation
Figure displaying a radioactive distribution inside a patient with initial intensity I0.
When the gamma ray travels through the patient, it will experience attenuation through
either photoelectric absorption (gamma ray A), or scattering (gamma ray B).

The gamma rays that are measured by the detector will have a measured intensity
value of I. µ is the linear attenuation coefficient of the object and is dependent on its
composition, and S is the path the gamma ray travels before reaching the detector (figure
1.1). These are related through the following equation for attenuation [28]:
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I = I oe

∫

− μ ( x , y ) ds
S

(1.1)

I0 = reference intensity
I = measured intensity
S = Path taken by gamma ray
μ(x,y) = linear attenuation coefficient as a function of location in tissue
ds = differential of the tissue thickness encountered along path S
Scatter can also be defined as the detection of mis-positioned gamma rays. The
presence of scatter in SPECT imaging generally degrades image contrast and
compromises quantitative accuracy. In SPECT, gamma rays can become mis-positioned
through the physical phenomenon of Compton scattering. In Compton scattering, a
gamma ray emitting from a decaying radionuclide is deflected from its original trajectory
but is detected anyway. Fortunately, since the energy of Compton scattered gamma rays
are different from those of primary gamma rays, they may be distinguishable through
energy discrimination. Thus, the energy of each gamma ray is measured as it is detected.
If that gamma ray’s energy falls outside a pre-set tolerance – commonly referred to as an
energy ‘window’ – then that gamma ray can be rejected. A common window for clinical
SPECT using

99m

Tc is 140 keV +/-7.5%. However, scatter rejection by energy

discrimination is not perfect: in clinical SPECT imaging, a 140 keV +/-7.5% energy
window contains approximately 1/3 scattered gamma rays [31]. Reducing this scatter is
the subject of extensive research, and is described in section 1.6.
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Figure 1.2: Scatter
Figure displaying the effect of scatter that occurs within an object. Gamma rays that
should have been detected at a certain location are detected elsewhere due to the scatter
interaction.

A third important source of image quality degradation is the loss of spatial
resolution due to the physical collimator on a gamma camera and the intrinsic spatial
resolution of the detection crystal. The collimator consists of a series of holes separated
by septa, made from a material with high atomic number, such as lead. Typically, the
holes are hexagonal in shape and arranged into a honeycomb (see figure 1.3).
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Figure 1.3: Collimator holes
Figure displaying the hexagonal holes of the collimator arranged in a honeycomb pattern.
The number of holes typically range from 10000 to 150000. The hole diameter (D) can
range from 1 mm to 3 mm

As stated previously, the purpose of the collimator is to admit gamma rays
traveling in a preferred direction (i.e. perpendicular) relative to the imaging plane, and
reject other gamma rays. In practice, however, collimators admit gamma rays with a
small angular deviation away from the perpendicular imaging plane. The geometry of
this ‘acceptance angle’ strongly influences spatial resolution on the imaging plane (see
figure 1.4). In fact, the spatial resolution on the image becomes a function of the distance
between the source of gamma rays and the collimator [30]. This phenomenon is referred
to as distance-dependent resolution. The acceptance angle can be reduced by making the
collimators holes smaller in diameter or increasing the length of the septa (figure 1.4),
leading to improvements in spatial resolution. However, the trade-off to reducing the
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acceptance angle is a decrease in sensitivity, leading to increases in image noise due to
the decrease in signal. The following equation can be used to relate the distancedependent resolution (figure 1.4):

R = D ⋅ tan(Φ )
Where R = Resolution
D = Distance from point source to crystal
Φ = Acceptance angle

(1.2)
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Figure 1.4: Distance-dependant blurring
This figure demonstrates how a radioactive point source is blurred due to the acceptance
angle of a parallel hole geometry collimator. D is the distance from the point source to
the crystal, H is the hole diameter of the septa, while L is the length.

1.4 TOMOGRAPHIC RECONSTRUCTIONS IN SPECT
Many algorithms have been developed for tomographic reconstruction from
projection data. Up until the past decade, the most popular algorithm was filtered backprojection, which was adapted from X-ray Computed Tomography [32]. Although
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computationally efficient, filtered back-projection did not allow the reconstruction of
quantitative images in SPECT. This was due primarily to the inability to incorporate the
physics of gamma ray propagation into the filtered back-projection algorithm, and to a
lesser extent, the inaccurate modeling of Poisson noise in gamma ray detection [33].
Today, filtered back-projection has been replaced extensively with iterative
reconstruction.

Although

much

more

computationally

demanding,

iterative

reconstruction can incorporate gamma ray attenuation, Compton scatter, and distancedependent resolution effects, as well as modeling noise properly [34].
We provide a brief introduction to iterative reconstruction. The reader is referred
to [35] for a detailed review. First, we consider the process of measuring a distribution of
radioactivity using a gamma camera. Let the vector F, with size M×1 and elements
f1…fM, be a discretized representation of the distribution of radioactive disintegrations in
a region that we are interested in measuring. The elements of F represent the individual
volume elements, or voxels, of the object. Let the vector G, with size N×1 and elements
g1…gN, represent the pixel-by-pixel measurements of the radioactivity as recorded by a
gamma camera as it rotates around the source of radioactivity – the elements of a
sinogram. Thus G would be a measure of the projection of F. This can be written
mathematically as:

G = AF

(1.3)

Where A is an N×M matrix. Each element in A, corresponds to the probability that the
gamma ray emitted in a particular voxel is detected by a particular pixel at a particular
gamma camera position (during its rotation around the radioactive source). For example,
elements in A represent the probability that voxel fi emits gamma rays that are recorded
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by the gamma camera in pixel gj. Equation (1.3) is commonly referred to as the forward
projection, and A the transition matrix. The attractiveness of iterative reconstruction lies
in the flexibility of the transition matrix. The transition matrix can include extremely
detailed models of the physics of both photon propagation in non-uniform media and
detection with a gamma camera. Various groups have developed methods to include
attenuation effects using radioisotope transmission images [36, 37] or X-ray CT [38, 39,
40] or even MRI [41]. Incorporation of Compton scatter, although more computationally
demanding, has received considerable attention [42, 43], as has distance-dependent
resolution effects [44].
One of the most popular iterative reconstruction algorithms is MaximumLikelihood Expectation Maximization (MLEM), introduced to the nuclear medicine
society by Shepp and Vardi [45], and Lange and Carson [46]. We provide a brief
introduction to the algorithm, but the reader is referred to Lange and Carson [46] for a
detailed derivation. The objective of tomographic reconstruction is to solve Equation
(1.3) by finding the best estimate of F: the mean number of radioactive disintegrations in
the measurement region that can produce the measurements G with the highest
likelihood assuming Poisson statistics. The MLEM formula is designed to find this best
estimate of F. It can be written as [46]:
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(1.4)

k +1

Where f m = new estimate
k

f m = old estimate
g n = measured number of counts
n = bin number
m = pixel number
k = iteration number
anm = probability photon emitted from mth pixel will be detected in nth bin

This equation seems complex at first presentation, but is simply a set of
successive projection and back-projection operations. It can be expressed more simply in
words [47]:
Image (k+1) = Image (k) × Normalized Backprojection of Measured Projections
Projection of image (k)

(1.5)

The MLEM algorithm requires a starting estimate of the image to be
reconstructed, referred to as F0 in Equation (1.4) or Image0 in Equation (1.5). This is
often a uniform disk of the value 1. As the MLEM iterations proceed, the image
gradually converges to the tomographic representation of the original distribution of
radioactivity that was measured. My research utilized a modified version of MLEM
known as Ordered Subsets Expectation Maximization (OSEM) [48]. Studies have shown
that OSEM converges to a useful image faster than MLEM, and so it is sometimes
termed an accelerated version of MLEM. Similar equations and process previously
described are used by both algorithms, but are implemented differently. For the case of
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MLEM a projection/back-projection calculation must be done for every projection angle
before an updated estimate can be generated. In OSEM, only a portion of the projection
angles are projected and back-projected for each iteration. Successive iterations utilize
different subsets, gradually stepping through all projection angles.
Attenuation, scatter, and distant-dependent resolution are important forms of
image degradation. For the purpose of this thesis we will discuss methods to compensate
for all these physical effects, but will concentrate more on attenuation correction since
this thesis’ primary focus is on methods of attenuation correction.

1.5 CORRECTING FOR ATTENUATION IN SPECT
To correct for the effects of attenuation the distribution of electron density must
be determined in the object being imaged. Two popular methods for measuring density
include radioisotope transmission imaging [37], and more recently X-ray Computed
Tomopgraphy – leading to the so-called Hybrid SPECT/CT [38]. The technique of
radioisotope transmission imaging placed a gamma-ray emitting radioisotope adjacent to
the patient but opposite to the gamma camera, as shown in figure 1.5. The gamma
camera would record the passage of gamma rays through the patient, and then repeat that
measurement without the patient. By comparing the two measurements and by using the
principles of computed tomography, one could calculate the distribution of attenuation
inside the patient’s body [49]. The advantages of radioisotope transmission imaging are a
large field of view and a relatively small radiation burden. Perisinakis et. al. [50] report
that for a 153Gd radioisotope source, the radiation dose would be approximately 3.2 µSv,
and since both transmission and emission could be performed simultaneously (with some
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implementations) there would be only minimal probability of mis-registration between
the patient’s SPECT scan and their attenuation map [37]. Some disadvantages include
the requirement of high activity radioisotope source, and the final attenuation maps
tended to have poor spatial resolution and considerable noise [49].

Figure 1.5: Transmission imaging with a scanning line source
Figure displaying a dual detector SPECT camera with a scanning line source
transmission imaging system.

Over the past decade, radiosotope transmission imaging was gradually replaced
with X-ray Computed Tomography (a concept first proposed by Hasegawa [51]),
bringing about the hybrid SPECT/CT scanner.

X-ray CT had several important

advantages over radioisotope transmission imaging, including (i) images of sufficient
resolution and low-noise to offer some diagnostic value, (ii) images acquired fast enough
(depending on the implementation) to be relatively free of motion artifacts, and (iii) a
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radiation source that could be de-activated and would not decay. Disadvantages include:
the SPECT and CT are acquired sequentially providing the potential of mis-registration,
and higher costs and radiation dose [49].
One chapter of this thesis examines two different SPECT/CT systems, where the
two systems are differentiated primarily based on their CT rotational speed. One system
utilizes a slow-rotation CT for acquiring the transmission data. In this scenario the X-ray
tube and detector are attached to the gamma camera gantry, and therefore can only rotate
as fast as the gamma camera gantry, which is approximately 15 seconds for a full 3600
rotation. For each rotation four slices of data are acquired, with each slice being 5mm
thick. Scanning a 10cm axial field-of-view therefore requires approximately 5 minutes.
This period of time is too long for a patient to hold their breath, thus patients are freely
breathing during data acquisition. Although these images are subject to respiratory
motion, they still have a much better spatial resolution than those acquired via
radioisotope transmission imaging. Although the images are not of diagnostic quality,
some studies have shown that for attenuation correction an image of diagnostic
resolution is not required [52, 53]. In terms of ionizing radiation burden to the patient:
for a rest/stress cardiac scan (which is a typical SPECT/CT application), two CT scans
would be required for a combined dose of 0.5mSv [54]. Despite this dose being higher
than from radioisiotope transmission imaging (few micro Sieverts [50]) it still compares
favourably relative to the dose attributed to the injected radiotracer – which is
approximately 12.5mSv [26].
A second SPECT/CT design features a SPECT scanner coupled to a high-speed
CT capable of producing images of diagnostic quality. A typical 360o rotation speed for
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such a system is 0.6 seconds, while acquiring between 6 to 64 slices per rotation. This
high speed enables a CT acquisition within a single breath-hold, which eliminate motion
artifacts related to breathing, and therefore yields a higher contrast image. The improved
image quality however, is associated with increased ionizing radiation dose: the CT
portion of a cardiac rest/stress scan will contribute 2-4mSv of radiation burden to the
patient [55].

1.6 CORRECTING FOR SCATTERED GAMMA RAYS IN SPECT
In SPECT imaging, the gamma ray detects both primary gamma rays as well as
scattered gamma rays. One method of reducing scatter content is to reject scattered
gamma rays via energy discrimination. Currently, this is employed by all gamma
cameras, as previously described. For example

99m

Tc imaging is frequently acquired

using an energy window centered at 140 keV, with a 15% width. Gamma rays with
energies outside that range are rejected – but low-angle scatter is still admitted. In
principle one could further remove scatter rejection by reducing the width of the energy
acceptance. Unfortunately this width is ultimately limited by the finite energy resolution
of the gamma camera, which is approximately 10%. In an effort to improve energy
resolution, recent efforts have focused on solid state detectors which replace both the
scintillation crystal and photomultiplier tubes found in conventional gamma cameras .
Solid-state detectors using either Cadmium Zinc Telluride (CZT) or Cadmium Telluride
(CdTe) are currently being studied [56]. Early indications have demonstrated that these
materials could improve the energy resolution to approximately 5% -- a substantial
improvement over conventional gamma cameras [57, 58, 59].

21
Despite the use of energy discrimination, some scattered gamma rays cannot be
differentiated from primary gamma rays and thus end up being included during data
acquisition. The presence of scatter in SPECT degrades resolution and image contrast,
and therefore it is desirable to minimize its presence. A popular method of scatter
correction used clinically is to acquire projection data from energy windows adjacent to
the photopeak window, and use this data to estimate the distribution of scatter in the
photopeak energy window. In 99mTc radioisotope imaging (which represents the majority
of SPECT imaging), a typical scatter correction is the “dual-energy” scatter correction
method first presented by Jaszczak et al [60] and later refined by Ogawa et al [61],
illustrated in figure 1.6.

This scatter correction method assumes that the spatial

distribution of scattered gamma rays in the photopeak energy window is the same as all
gamma rays recorded in the adjacent (lower energy) window. The scatter correction is
effected by scaling the data recorded in the adjacent energy window by an
experimentally-determined constant and then subtracting that scaled data from the data
measured in the photopeak energy window. After the scattered gamma rays are removed
from the photopeak projection data, the ‘corrected’ measurements are processed for
tomographic reconstruction. For the case of radio-isotopes that have two energy peaks,
which is the case of

111

In, down-scatter is present at the photo-peak centered at 173keV

coming from the higher photo-peak centered at 247keV. In this situation a triple-energy
window (TEW) scatter correction method is used by placing one scatter window just
below and one just above the primary window around 173keV (figure 1.6) [62].
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Figure 1.6: Scatter correction techniques
For 99mTc imaging and “dual energy” scatter correction a narrow window just below the
photopeak window is chosen. With this scatter window a triangle is made, with the
height equivalent to the average number of counts measured in the scatter window, and
the base being the width of the primary window. The area under this triangle is an
estimate of the scatter measured in the photopeak window. Scatter correction is then
implemented by subtracting this scatter estimate from the counts in the photopeak
window. For

111

In imaging and TEW scatter correction a trapezoid is formed with the

scatter windows above and below the photopeak window, with the base being the width
of the photopeak window, and the area under the trapezoid would be subtracted from the
photopeak window to correct for scatter.
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1.7 CORRECTING FOR DISTANCE-DEPENDENT RESOLUTION IN SPECT
The detector and collimator response functions can be measured and incorporated
into the iterative reconstruction algorithm to compensate for the distance-dependent
resolution [63]. To measure the detector response function the collimator is removed and
a lead plate consisting of a narrow slit is placed on the NaI(Tl) crystal and is irradiated
with a radioactive source. The FWHM of this slit is then measured and is typically
calculated to be approximately 4.0mm. It should be noted that the detector response is
not dependent on distance.

The collimator response function is however distance-

dependent (as discussed in Section 1.3), and can be measured with a line source of
activity placed at different distances from the collimator. The line profile of the activity
source is measured at different distances and fit to a Gaussian function and the FWHM is
measured.

The FWHM of the detector and collimator response functions are then

combined and plotted to fit a line. This data is then incorporated into the transfer
function of the iterative reconstruction algorithm to correct for distance-dependent
blurring in a SPECT image.

1.8 TOWARDS THE MONITORING OF CARDIAC STEM CELL THERAPY
USING SPECT/CT
My thesis explores several technical challenges associated with the use of
SPECT/CT in monitoring cardiac regenerative therapy. This first aspect concerns the
adoption of solid-state gamma cameras, which is inevitable if their costs continue to
decrease.
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Since stem cells are sensitive to radiation dose, it is desirable to label them with
as little radioisotope as possible. Our group has performed studies to determine the
toxicity levels acceptable for cells to continue to proliferate, which was shown to be 0.1
Bq of

111

In per cell, for the case of bone marrow derived mesenchymal stem cells [25].

In our studies involving canine models of heart disease, we would aim to transplant
approximately 30 million cells [64]. Thus, at most, the activity transplanted to a target
site (such as an infarction) would be 3 MBq. This activity level is much lower than the
20 to 30MBq of

111

In used to label white blood cells in routine clinical applications. In

addition, these cells are widely dispersed throughout the whole body, as opposed to the
limited geographic distribution of the transplanted stem cells. With such a limited
amount of radioactivity, greater attention must be paid to maximizing image quality
including the implementation of corrections for the physical effects of gamma ray
attenuation and scatter. One opportunity for minimizing the presence of scatter in SPECT
may lie with the adoption of solid-state gamma cameras. Compared with conventional
gammas cameras utilizing scintillation crystals and photomultiplier tubes, solid-state
detectors can achieve superior energy and spatial resolution, in addition to enhanced
image contrast [56]– all of which would benefit imaging transplanted radiolabeled cells.
The use of solid-state gamma cameras is currently limited due to very high
manufacturing costs, especially for large field-of-view (FOV) detectors.

For the

application of monitoring cardiac stem cell therapy, however, a large FOV detector may
not be necessary since the region of interest – the heart – is relatively small. However, in
general, the use of small detectors requires caution since object truncation always
becomes more of a concern [65, 66]. However no one has addressed the problems of
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image truncation when performing hot-spot imaging. It will be shown that provided the
hot-spot is within each projection that truncation is less of a problem if the reconstruction
method is guided by an anatomical imaging method such as CT.
When imaging radioactive distributions larger than the gamma camera, artifacts
caused by object truncation can appear at the periphery of the FOV. These artifacts can
be especially prominent in iterative reconstructions, and are the result of the
reconstruction algorithm attempting to find a distribution of activity in that FOV most
consistent with the projection data (as described in Section 1.4 earlier). However, since
there is by definition, radioactivity beyond the FOV, the algorithm converges to an
incorrect solution; and the error is seen as the “hot rim” truncation artifact.
Correcting for truncation artifacts is important when imaging a small FOV
because the artifact can easily interfere with the imaging of the object of interest.
Methods for correcting image truncation have been discussed in the past [66, 67]. In
CHAPTER 4, I evaluate an iterative reconstruction algorithm modified to reduce the
presence of truncation artifacts. The algorithm is evaluated in the context of cardiac
imaging where the imaging apparatus is a small FOV gamma camera coupled to a large
FOV X-ray CT.
The low amount of activity used in cardiac stem cell therapy monitoring using
SPECT emphasizes the need for dealing with the physical effects of scatter and
attenuation. The previous section introduced the necessity for improved scatter rejection;
however, the matter of gamma-ray attenuation will also need to be addressed. Currently
the most widely implemented method for attenuation correction is via X-ray CT.
However, as previously described, two CT designs exist for SPECT/CT systems; a slow-
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rotation CT and a fast-rotation CT. We should note a third CT design exists that
incorporates a flat panel x-ray detector that can image the entire chest in a single rotation.
At the time of the experiments the flat panel design was not available and therefore the
latter two were studied. Experiments were required to determine which design will
perform a more correct method of attenuation correction. In Chapter 2, I study how
respiratory motion impacts the quality of cardiac SPECT imaging when attenuation
correction is based on fast vs slow rotation CT. I evaluate both designs using computer
simulations and experiments in a canine model.
Many aspects of cardiac stem cell therapy remain to be studied and optimized.
To achieve successful cell therapy, it is believed that cells should be transplanted into the
periphery of the infarct, and not directly in the infarct center where blood flow is
compromised [68]. Therefore, methods to properly localize transplanted cells in relation
to blood flow must be developed. Here, SPECT can offer a solution due to its multispectral imaging capabilities. We previously demonstrated the ability of SPECT to
image simultaneously, in a canine model, cardiac-transplanted
myocardial perfusion using

99m

Tc-MIBI, and an

111

In-labeled cells,

131

I-labeled FIAU reporter probe (See

Figure 1.7). However, the resolution of the SPECT blood flow image with

99m

Tc is not

ideal to properly localize the cells relative to the region of reduced blood flow. CT has
been shown to be a viable alternative for perfusion imaging [69, 70], and has the
resolution required to localize the

111

In labeled cells seen on SPECT. Recent studies

have confirmed that the CT in hybrid systems such as PET/CT can be used for perfusion
imaging [71]. In Chapter 3, I demonstrate a newly developed method of combining
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SPECT with first-pass perfusion CT for the localization of cells in relation to region of
reduced blood flow in a canine model of myocardial infarction.

Figure 1.7: Multi-spectral imaging using SPECT
SPECT is capable of imaging multiple isotopes simultaneously.
example of a canine study, the injected cells were labeled with
cardiac perfusion image was obtained with

In this particular
111

In (GREEN), the

99m

Tc (RED), and a reporter probe imaged

with 131I (BLUE). All of these isotopes are combined to form a single image.
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CHAPTER 2:

CARDIAC SPECT/CT: SLOW CT OR FAST CT?

2.1 INTRODUCTION
For many decades SPECT has been routinely used for myocardial perfusion
imaging [1]. However, the diagnostic quality and quantitative accuracy of SPECT is
affected by the physical effects of attenuation and scatter [2, 3], and therefore, SPECT
would benefit from proper correction of these physical effects. The dominant effect
reducing quantitative and diagnostic accuracy in cardiac SPECT is photon attenuation [4,
5, 6, 7]. In the past, non-uniform attenuation correction in SPECT was accomplished by
way of radioisotope transmission imaging [8, 9, 10, 11, 12, 13, 14, 15, 16, 17]. Some of
the challenges of radioisotope transmission imaging are limited resolution in the
attenuation map, longer acquisition times that may increase the likelihood of patient
motion, conversion of attenuation coefficients from the transmission energy to the
emission energy, cross-talk between the transmission and emission data acquisitions, and
the cost of frequently replacing the transmission radioisotope [4, 18, 19, 20, 21, 22, 23,
24, 25, 26, 27, 28]. The natural progression of transmission imaging moved toward x-ray
CT [29], in part to address these concerns, and in part to provide the added benefit of
improved anatomical localization.
Following the success in PET/CT [30], several manufacturers are now developing
hybrid Single Photon Emission Computed Tomography / X-ray Computed Tomography
(SPECT/CT) platforms [31].

The concept of utilizing CT for SPECT attenuation

correction and image fusion has been studied even before the development of PET/CT
[23, 32, 33]. The importance of SPECT/CT lies with the desire to provide anatomical
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context to the functional information provided by SPECT, and the growing recognition
that, in SPECT, attenuation is inherently non-uniform and correcting for its effects
requires knowing the distribution of tissue density in the body with high spatial
resolution [28]. Thus, moving to CT was received well, and it largely eliminated the
problems associated with radioisotope transmission imaging [29, 30, 33, 34, 35]. In fact,
a multi-centre evaluation of attenuation correction using both x-ray CT and radioisotope
transmission imaging concluded that a high-quality attenuation map provided the best
results when comparing uniformity in normal myocardium and defect contrast [36].
Attenuation correction depends upon the registration accuracy between SPECT
and CT [37] and that the attenuation map matches the conditions under which the SPECT
scan was acquired. In SPECT, due to the axial length of the gamma camera
(approximately 30cm), all tomographic slices can be acquired simultaneously. Although
some manufacturers acquire data with a gamma camera in continuous rotation, the
majority of them acquire data in a stop-and-acquire manner, with each projection lasting
about 5 to 20 seconds, depending on the application. Thus, when imaging the torso in
SPECT the acquisition of each projection is averaged over the multiple phases, or even
multiple cycles, of the respiratory cycle. CT gantries, on the other hand, move much
faster and in a continuously rotating manner. In merging SPECT and CT platforms,
manufacturers have taken one of two approaches to CT design. In the "slow rotation"
design, a CT gantry completes a full 360o rotation in approximately 15 seconds [8]; thus
each CT projection is acquired during a different phase of the respiratory cycle, since
breathing is maintained. Upon reconstructing data acquired in this manner, transaxial
slices are often found to contain radial streaking artifacts that could have negative
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implications for attenuation correction [38]. The "fast rotation" design completes a full
3600 rotation in as little as 0.6 seconds, allowing all projections to be acquired during a
single phase of the respiratory cycle (i.e. a breath-hold). With either design, the CT data
will not be registered to the SPECT due to respiratory motion during the acquisition of
the latter [39, 40], and hence quantitative accuracy will be compromised [41, 42, 43].
Given the above disparity between the methods of acquiring SPECT and CT, the
question then arises: which is more suitable for SPECT attenuation correction, "slow
rotation" or "fast rotation" CT? The idea of using a slow rotation or fast rotation has
already been under debate in PET/CT systems [44]. Phantom and clinical studies have
already demonstrated that a slow-rotating CT design in SPECT/CT provides adequate
resolution and anatomical localization capabilities for attenuation correction purposes
[45, 46], but studies comparing it to fast-rotation CTs have not been published. The
purpose of this work was to compare “slow-rotation” with “fast-rotation” CT for their
ability to correct for non-uniform attenuation in cardiac SPECT/CT taking into account
the impact of physiological motion in both computer simulations and canine
experiments.

2.2 METHODOLOGY
2.2.1 Computer Simulations
Computer models were developed of SPECT/CT systems with two CT designs.
The slow-rotation CT design has a full-orbit (3600) rotation time of 15 s, with slice
thickness of 5 mm and acquires 4 slices per revolution. The fast-rotation CT features a
full-orbit rotation time of 0.6 s, with 1.0 mm slice thickness and a 6-slice detector. These

38
models were meant to approximate the CT designs of the Infinia/Hawkeye-4 (General
Electric, Waukesha, WI, USA) (slow CT) and Symbia/T6 (Siemens, Erlangen, Germany)
(fast CT), both of which are in widespread clinical use.

Cardiac computer phantom
Our study used the 4DNCAT [47] digital phantom (see fig 2.1a), which simulates
the human chest, including organs in a 3-dimensional spline frame, and features
physiologic motion.
For this experiment, motion due to respiration was simulated, wherein the heart
moved axially by a maximum of 2.3 cm. The cardiac cycle was not simulated. A five
second sinusoidal breathing period was used, which was divided into ten frames
comprising the respiratory cycle (0.5 s/frame). The 2.3 cm cardiac displacement is
typical in humans during quiet breathing from rest or functional residual capacity (FRC)
to FRC plus tidal volume (TV) [48]. Greater displacement would occur in respiratory
disease with increased TV (i.e. emphysema), or during non-quiet breathing (i.e.
sighs/yawns). The phantom was configured to simulate the distribution of the radiotracer
99m

Tc-MIBI, which is commonly used to evaluate myocardial viability (see fig 2.1b). The

concentration of the radiotracer in each organ was derived from patient scans acquired in
our clinic. The 4DNCAT phantom was also used to simulate the CT scans, which were
converted into 140keV equivalent attenuation maps.

Attenuation coefficients were

calculated from measured values collected in clinical scans, which concur with published
values [49]. These attenuation coefficients were for a narrow-beam CT acquisition. We
have converted these results to provide broad-beam attenuation coefficients [50], to
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compensate for the effects of scatter (Soft tissue = 0.12; Bone = 0.18; Lung = 0.04)
during SPECT reconstruction.

Figure 2.1: The computer phantom model of the chest
(A) 4DNCAT phantom displaying the organs that are simulated.

(B) Activity

distribution of the different organs. The ratio of the activity distribution was taken from
clinical scans at our institution (soft tissue:lung:heart = 2:4:75).

Simulation of SPECT data acquisition
SPECT was simulated using SimSET (University of Washington, Division of
Nuclear Medicine), which is a Monte Carlo based simulation software that models the
physical effects of photon propagation in the phantom and the performance
characteristics of typical SPECT systems. For the case of these simulations we used a
typical parallel hole collimator (thickness = 2.405 cm; hole radius = 0.0555 cm; septal
thickness = 0.016 cm), and with a detector crystal modelled to have a 10% intrinsic
energy resolution. For SPECT, 1.5M counts were simulated to be detected over 128
projections over 360 degrees using 128x128 projection matrices. These parameters are
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typical in our clinical cameras and cardiac procedures. The SPECT simulation was gated
to the same respiratory cycle as the 4DNCAT phantom; therefore, 10 SPECT
acquisitions were obtained providing approximately 150k counts per frame of the
respiratory cycle.

Simulation of X-ray CT data acquisition
To model the slow rotation CT, different points in the respiratory cycle were
selected and projected into arc-segments of the radon transform, leading to a set of
inconsistent projections. These projections were tomographically reconstructed using
filtered-backprojection, resulting in “motion-corrupted” tomographic slices, which were
then used as the attenuation map in SPECT iterative reconstructions (see Fig.2.2A). To
model the fast rotation CT, the respiratory cycle was fixed at FRC for the entire
acquisition, and used as the attenuation map [51] in SPECT iterative reconstruction (see
Fig.2.2B). As well nine other fast CT acquisitions were simulated, each one taken at a
single point in the respiratory cycle progressing from the (FRC phase + TV/5) to (FRC +
TV) and back down to FRC corresponding to a total of 10 CT data sets equally
separating the cardiac displacement over 2.3cm.

Simulated SPECT/CT data reconstruction
SPECT data were reconstructed using an ordered subset iterative reconstruction
algorithm [52] with four different scenarios:
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(1)

For the slow rotation CT, each of the 10-gated SPECT acquisitions
were reconstructed using the single motion-corrupted CT as the
attenuation map. (gated-SPECT/slow-CT)

(2)

For the fast rotation CT, a breath hold CT at FRC was used as the
attenuation map for each of the 10-gated SPECT reconstructions.
(gated-SPECT/fast-CT)

(3)

Reconstructions of the gated SPECT acquisitions with the
corresponding gated CT as the attenuation map were used as our gold
standard. (gated-SPECT/gated-CT)

(4)

Finally, reconstructions with no attenuation correction were performed
on the 10-gated SPECT acquisitions. (gated-SPECT/no-CT)

2.2.2 Analysis of computer simulations
Simulated attenuation maps
A comparison of the slow rotation CT and fast rotation CT attenuation maps with
that of the gold standard was measured through the use of a linear sum algorithm [54].
The same central slice of the heart was taken for each map, and the sum of all lines
(linear sum) from the centre of the attenuation map towards the exterior was taken for
128 angles spaced uniformly over 360 degrees (figure 3A).

The RMS error was

measured between the slow rotation and fast rotation CT attenuation maps with that of
the gold standard for each of the 10 frames in the respiratory cycle using the following
equation:
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1
N

⎛ GOLD(map) i − TEST (map) i
⎜⎜
∑
GOLD(map) i
N ⎝
i

2

⎞
⎟⎟ ×100
⎠

(2.1)

Where,
i = angle
N = Total number of angles (360)
GOLD(map) = Gold standard attenuation map
TEST(map) = Slow rotation or fast rotation CT derived attenuation map
Simulated SPECT reconstructions
A polar plot was constructed for each of the reconstructed data in all four
scenarios (1 to 4 from section 2.2.1: Simulated SPECT/CT data reconstruction) using inhouse software [53]. To analyse and compare the different reconstruction methods the
polar plots were compared in a pixel-by-pixel manner for each of the 10 frames of
respiratory cycle and the root mean squared (RMS) error between (1) and (3), (2) and (3),
and (4) and (3) was calculated as:
2

1 i ⎛ GOLDi − SIM i ⎞
∑ ⎜ GOLD ⎟⎟ × 100
N N ⎜⎝
i
⎠

(2.2)

Where,
i = pixel
N = total number of pixels
GOLD = Gold Standard (gated-SPECT/gated-CT) and,
SIM = Attenuation corrected reconstruction with slow CT (gated-SPECT/slow-CT) OR
fast CT (gated-SPECT/fast-CT)
Note: The summation is taken over all pixels in the polar plot.
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2.2.3 Canine experiments
Canine studies were approved by the Animal Use Subcommittee at the University
of Western Ontario. A total of three adult canines (20 kg average mass) were used for
this study.

For each experiment the canine was injected with 400MBq of

99m

Tc-

methoxyisobutylisonitrile (99mTc-MIBI) for myocardial perfusion imaging, and
underwent cardiac SPECT/CT scans using an Infinia/Hawkeye-4 (General Electric
Healthcare, Waukesha, WI, USA) (slow rotating CT), and a Symbia/T6 (Siemens
Medical Systems, Erlangen, Germany) (fast rotating CT) and, both of which use dualhead SPECT. SPECT scans were acquired using 128 projections over 360 degrees (64
projections over 180 degrees per gamma camera head), 128x128 image matrices, and
high-resolution parallel hole collimators (Symbia/T6: thickness = 2.405 cm; hole radius
= 0.0555 cm; septal thickness = 0.016 cm, Infinia/Hawkeye-4: thickness = 3.5 cm; hole
radius = 0.075 cm; septal thickness = 0.02 cm).
The canine was kept alive for a period of 1.5 hours to maximize the 99mTc-MIBI
uptake.

After which point the canine was euthanized and imaged on the

Infinia/Hawkeye-4 SPECT/CT 4 hours post-mortem.

Myocardial perfusion cardiac

SPECT/CTs were performed with no ventilation (no respiratory motion: slow gold
standard), and followed with assisted ventilation at 8 breaths/min to simulate respiratory
motion.

For the case of the Infinia/Hawkeye-4 scans the euthanized canines were

ventilated for both the SPECT and CT portion due to the longer scan time for the slow
rotation CT. The CT scan consisted of 5 mm thick slices. The time per projection for
the SPECT scan was chosen to achieve a 1.5M count level for the entire slow gold
standard scan (~35 s/projection), which is what is typically seen for clinical acquisitions.
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To compensate for the effects of physical decay of the 99mTc, the time/projection for the
SPECT scan with respiratory motion was increased to provide approximately the same
total counts per projection as the slow gold standard scan.
The canine was then scanned on the Symbia/T6 7 hours post-mortem with no
respiratory motion (fast gold standard), followed by another while the canine was
ventilated (8 breaths/min) to once again simulate the motion of breathing. Since the
Symbia/T6 is equipped with a fast rotating CT, the CT for this case was taken at end
expiration (no ventilation) to simulate the acquisition at FRC that would have occurred if
the canine was alive. The CTs of the chests were once again performed at a slice
thickness of 5mm to be comparable to that of the Infinia/Hawkey-4’s slow rotating CT.
The time per projection for the SPECT scan was once again chosen to achieve a 1.5M
count level for the entire fast gold standard scan (~45 s/projection). To compensate for
the effects of physical decay of the

99m

Tc, the time/projection for the SPECT scan with

respiratory motion was increased to provide approximately the same total counts per
projection as the fast gold standard scan.
All the data from the Infinia/Hawkeye-4 canine experiments were reconstructed
on the Xeleris workstation (version 2.0532) (General Electric Healthcare, Waukesha, WI,
USA) and all the data from the Symbia/T6 canine experiments were reconstructed on the
Symbia workstation (version 8.1.15.7 SP2) (Siemens Medical Systems, Erlangen,
Germany). Clinical cardiac reconstruction parameters were used (ordered subset
expectation maximization (OSEM) iterative algorithm consisting of 3 iterations, 16
subsets). In addition all reconstructions were normalized to the total counts in the image,
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which corresponded to the gold standard for either the slow rotation CT or fast rotation
CT equipped SPECT/CT.

2.2.4 Analysis of canine experiments
Experiments performed on the Infinia/Hawkeye-4 and the Symbia/T6 each had
their own gold standard, which consisted of imaging with no respiratory motion
(euthanized canine). Since changes in anatomy occur post-mortem [55], imaging on the
Infinia/Hawkeye-4 commenced approximately 4 hours post-mortem, and images
acquired while the canine was ventilated (with respiratory motion) were compared to
images acquired with no respiratory motion. A region of interest (ROI) in a central slice
of the heart was chosen and an RMS error was calculated between the two sets of images
using the following equation:
1
N

i

∑ (GOLD

− VENTILATED i ) × 100
2

i

(2.3)

N

Where,
i = pixel
N = total number of pixels in slice
GOLD = Gold standard (no motion SPECT/CT reconstruction)
VENTILATED = SPECT/CT reconstruction with motion using either slow or fast CT
attenuation maps
Note: Ventilated data was normalized to total counts in gold data
In addition to the RMS error, the ventilated data for the Infinia/Hawkeye-4 and
Symbia/T6 was compared with the slow and fast gold-standard respectively using a
scatter plot of the same ROI in the central slice of the heart and a correlation coefficient
was recorded.
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2.3 RESULTS
2.3.1 Computer Simulations
Results of the slow- and fast-CT 4DNCAT computer simulations are shown in
Figure 2.2. Motion artifacts due to respiratory motion are readily apparent in the
attenuation map reconstruction from the data acquired by the slow rotating CT. The
artifacts can be seen in coronal and trans-axial planes, and are visualized qualitatively as
(i) blurring in the direction of motion, most evident at the base of the lungs in the coronal
plane, (ii) a contrast reduction in small structures, such as the ribs, and (iii) a background
“noise” seen throughout soft-tissue and lung regions. Additionally, in the trans-axial
plane, some radial streaking is apparent in soft-tissue regions around the periphery.
From a quantitative perspective a profile through the coronal plane confirmed blurring
artifacts at object boundaries, the loss of contrast of smaller structures and the presence
of noise. The fast CT simulated attenuation map provided an attenuation map without
blurring, contrast reduction and image noise.
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A

B

Figure 2.2: Comparing slow and fast CT attenuation maps
(A) Coronal slice of a slow CT attenuation map and a (B) fast CT attenuation map.
Profiles taken across the dashed-line in (A) and (B) are seen in (C). Trans-axial slice of a
(D) slow and a (E) fast rotation CT attenuation map at the level of the diaphragm. Notice
the motion artifacts associated with the slow CT, and the loss of contrast in the image
compared to the Fast CT acquisition at FRC.
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Simulated attenuation maps
The result of the linear sum analysis of the attenuation maps is shown in Figure
2.3. First, for the slow rotating CT and fast rotating CT, the overall RMS error, relative
to the gold standard (gated-CT) depends upon the respiratory frame. The slow-CT RMS
error is never zero, since it is never equal to the gold standard. However, with the fastCT, the RMS error is zero when comparing the same frame in the gold standard (gatedCT) that was used as the attenuation map for the fast-CT acquisition. By comparison of
the slow-CT and fast-CT attenuation maps the average RMS error across all frames of
the respiratory cycle improves from 2.4% to 1.5% respectively. Additional insight can
be gained by considering the angular dependence of the error in linear sums. Figure
2.3(A) illustrates the location of the linear sums as a function of angle. Figure 2.3 (B)
shows the linear sums as a function of angle for the slow-CT, the fast-CT as well as the
gold-standard (gated-CT) (frames #1 and #5 are both shown). Linear sums are a function
of angle as well as the frame in the respiratory cycle. For the slow-CT, linear sums are
different than the gold standard (gated-CT) for both frames in the respiratory cycle at
nearly all angles. For the fast-CT, linear sums are equal to frame #1 in the gold standard
for all angles since this was the frame chosen for the fast-CT attenuation map, but
substantial differences are noted for all angles when comparing fast-CT with the gold
standard (gated-CT) at Frame #5.
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Figure 2.3: Linear sum errors comparing slow and fast CT attenuation maps
(A) Image displaying profile lines taken across all angles of the attenuation map. (B)
Sum of profiles at each angle around the attenuation map for the slow-CT, fast-CT, and
the gold standard (gated-CT) (frame#1 and frame#5). Note that the profiles for ‘Gold:
Frame #1’ overlap with the profile for ‘Fast CT’. (C) RMS error per frame of respiratory
cycle between slow-CT and fast-CT attenuation maps compared to gold standard (gatedCT). Note: Frame #1 is equal to the FRC frame of the respiratory cycle.
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Simulated SPECT reconstructions
Figure 2.4 summarizes the RMS errors for each frame in the respiratory cycle
when analysing the computer simulation respiratory gated SPECT data reconstructed
with attenuation correction. The RMS error in this case is calculated relative to the gold
standard of gated-SPECT and gated-CT (gated-SPECT/gated-CT). The RMS error plot
in figure 2.4 follows a similar trend as the plot in figure 2.3C for both the slow-CT and
fast-CT attenuation maps. The RMS error for the first frame of the respiratory cycle was
zero when using the fast-CT attenuation map.

This is because the frame in the

respiratory cycle used for the CT attenuation map (simulation of FRC) was equal to the
frame of the respiratory cycle of the SPECT data that were collected. For the fast-CT as
we move further away from the initial frame (i.e. from FRC to FRC + TV), the RMS
errors increase, and gradually returns back towards zero as we return back to the
exhalation frame (i.e. FRC of the respiratory cycle). For the slow-CT attenuation map
the RMS error is never zero since the frame of the respiratory cycle of the CT data will
never be equivalent to the frame of the respiratory cycle of the SPECT data. The RMS
errors averaged across the frames respiratory cycle were found to be 4.2% for the
SPECT data corrected with the slow-CT attenuation maps (gated-SPECT/slow-CT), and
4.0% for the SPECT data corrected with the fast-CT attenuation map (gated-SPECT/fastCT). However, when no attenuation correction was used in SPECT reconstruction
(gated-SPECT/no-CT), the average RMS error increased to 68.1%, relative to the gold
standard (gated-SPECT/gated-CT).
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Figure 2.4: plot of error comparing SPECT reconstructions with slow and fast CT
attenuation correction (From equation 2.2)
RMS error plot per frame of the respiratory cycle, comparing the SPECT reconstructions
using slow-CT and fast-CT attenuation maps (gated-SPECT/slow-CT and gatedSPECT/fast-CT) with the gold standard (gated-SPECT/gated-CT). The RMS error using
the fast-CT at the first frame is zero, since this was the frame used for the fast-CT
attenuation map. The gated-SPECT/slow-CT RMS error is never zero, since the slowCT attenuation map is never equal that of the gold standard (gated-CT). The SPECT
simulations corresponded to 5 different lung volumes between FRC (frame #1) and
FRC+TV (peaking at FRC+TV in frame #6). The fast-CT was acquired at FRC, while
the slow-CT was acquired over 15s while the heart moved with a breathing period of five
seconds.
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To gain further insight into the origins of these errors, we compared count density
profiles across the left ventricle from gated-SPECT/slow-CT, gated-SPECT/fast-CT, and
gated-SPECT/gated-CT (gold standard) reconstructions. Figure 2.5 shows these profiles
taken at frame 2 (FRC + TV/5) and frame 8 (FRC + TVx3/5) of the respiratory cycle.
Using the slow-CT attenuation map (gated-SPECT/slow-CT), we notice a slight
reduction in count density compared to the gold standard (gated-SPECT/gated-CT). This
reduction is more pronounced for gated-SPECT/slow-CT frame 2 (See arrow in Figure
2.5a).
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Figure 2.5: Comparing profiles of SPECT reconstructions with slow and fast CT
attenuation correction
(A) Linear profile taken from frame 2 and (B) frame 8 from figure 2.4. Profile taken
across left ventricle of the heart. (C) Coronal slice of the left ventricle displaying the
location of the profiles taken across the heart. The profiles of the heart are comparing the
three different attenuation maps for image reconstruction. Notice the loss of contrast
when using Slow-CT attenuation map.

Note: gated-SPECT/fast-CT and gated-

SPECT/gated-CT (gold) profiles essentially overlap.
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2.3.2 Canine experiments
To remove the confound of comparing SPECT of a live canine with SPECT of a
deceased canine, we focused our experiments on recently deceased canines only.
However, to evaluate changes between living and deceased canines, we performed CT
scans on each canine prior to euthanization, as well as at multiple times points posteuthanization. Figure 2.6 shows that subtle differences are observed when comparing
pre- and post-euthanized canines. Figures 2.6 a-c illustrate an enlargement of the
mediastinum post-euthanization.
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Figure 2.6: Changes in canine anatomy post-mortem
(A) CT scan while canine was alive and being ventilated. (B) CT taken after canine was
euthanized, approximately 30min post-mortem, (C) 2 hours post-mortem, (D) 4 hours
post-mortem, (E) 5 hours post-mortem, (F) 7 hours post-mortem, and (G) 8 hours postmortem. For (A), (B), (C), (F), and (G) the CT scans were performed on the Symbia/T6
and were taken at functional residual capacity (FRC) by switching the ventilator off
during the scans. For (D) and (E) the CT scans were performed on the Infinia/Hawkeye4 with and without respiratory motion respectively. These images display the changes in
the canine heart anatomy immediately after post-mortem, and the stabilization hours
later.
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The RMS errors comparing slow and fast rotation attenuation correction in the
canine studies showed an improvement for all three canines when using the fast rotation
CT of the Symbia/T6 (table 2.1). Figure 2.7 and 2.8 displays the SPECT images for all
canines using the Infinia/Hawkeye-4 and the Symbia/T6 respectively. The scatter plot
and profile across the chest for the first canine is also shown.

The correlation

coefficients calculated for all three canines improved when using the fast rotation
attenuation map of the Symbia/T6 (table 2.2). The profile taken across the chest of
canine #1 comparing the reconstructions with and without respiratory motion shows near
perfect alignment for the Symbia/T6 (figure 2.8), as opposed to differences in contrast
and the position of the peeks for the SPECT reconstructions using data acquired from the
Infinia/Hawkeye-4 (figure 2.7).
Table 2.1: RMS error in Canine Studies
Canine
Infinia/Hawkeye-4
(Slow-CT attenuation map)
#1
#2
#3

44.4%
17.8%
21.9%

Symbia/T6
(Fast-CT attenuation map)
27.9%
9.8%
15.4%

Table 2.2: Correlation Coefficients in Canine Studies
Canine
Infinia/Hawkeye-4
Symbia/T6
(Slow-CT attenuation map)
(Fast-CT attenuation map)
0.71
0.92
#1
0.92
0.99
#2
0.92
0.96
#3
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Figure 2.7: Comparing images and scatter plots to gold standard for cardiac canine
SPECT/CTs using slow rotation attenuation maps
The first two columns are the central slices of the SPECT reconstruction using the
Infinia/Hawkeye-4 slow rotating CT attenuation map with and without respiratory
motion. A square ROI shown in canine #2 was used around the heart for the RMS error
calculation and scatter plots for all canines. The last column consists of a plot of the
profile across the heart and a scatter plot for canine #1 comparing the scan with and
without respiratory motion. The profile was taken across the orange dashed line shown
in the trans-axial image of canine #1.
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Figure 2.8: Comparing images and scatter plots to gold standard for cardiac canine
SPECT/CTs using fast rotation attenuation maps
The first two columns are the central slices of the SPECT reconstruction using the
Symbia/T6 fast rotating CT attenuation map with and without respiratory motion. A
square ROI shown in canine #2 was used around the heart for the RMS error calculation
and scatter plots for all canines. The last column consists of a plot of the profile across
the heart and a scatter plot for canine #1 to compare the scan with and without
respiratory motion. The profile was taken across the orange dashed line shown in the
trans-axial image of canine #1.
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2.4 DISCUSSION
The value of attenuation correction in cardiac SPECT/CT has long been the
subject of debate [56] with some authors in support of its use [57, 58] and others opposed
[59, 60]. Although multiple studies have shown the potential benefits of attenuation
correction in SPECT [61], there is now further debate as to how that attenuation
correction should be implemented [62].

Therefore, a study comparing SPECT/CT

systems available today is opportune to gain knowledge as to which route to take in
design of future SPECT/CT technologies.

To our knowledge, there are no cardiac

SPECT/CT publications comparing the respiratory motion artifacts arising from a slow
rotation CT or a fast rotation CT attenuation map that is compared with no respiratory
motion (gold standard). To this end, we performed both computer simulations using a
well established digital phantom [47], and performed experiments in canines which are
utilized widely as models of cardiac disease [63, 64, 65, 66].

2.4.1 Computer Simulations
We found that attenuation maps derived from a fast rotation CT had a lower RMS
error (1.5%) than those derived from a slow rotation CT (2.4%). The fast and slow
methods of CT data acquisition are different, both in terms of acquisition time per
rotation and spatial resolution. These differences can be visualized easily (Figure 2.2).
This improvement was found to propagate into the corresponding phantom SPECT
reconstructions, where the error was found to depend on respiratory frame, when using
both slow-CT and fast-CT attenuation maps. In the fast-CT case, the error ranged from
zero error when the fast-CT was in the same respiratory frame as the gold standard CT,
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to a maximum error when the fast-CT and gold-standard were at opposite frames in the
respiratory cycle. However, in the case of the slow CT attenuation map SPECT
reconstructions, the RMS error is less varied as a function of the respiratory frame. The
differences in SPECT reconstructions between slow-CT and fast-CT are minimized when
summing SPECT frames together to form an averaged SPECT. These ‘average’ RMS
errors are 4.0% and 4.2% for the fast-CT and slow-CT respectively.

2.4.2 Canine Experiments
Our canine experiments were performed on deceased animals to enable complete
control of the respiratory cycle, and image acquisition in the absence of respiratory and
cardiac motion.

Further, our study performed canine experiments in a design that

allowed each canine to be its own gold standard. Since each canine is different, and
cannot be compared to one another, the experimental design was set up in this manner to
properly evaluate the two SPECT/CT designs.
Figure 2.6 shows that, without respiratory motion, CT image quality is similar for
both fast and slow CT designs. However, in the presence of respiratory motion, slow
rotation CT images were found to contain radial streak artifacts, as previously reported
[38]; whereas the fast rotation CT remained free of motion artifacts. By referring to the
profile across the heart in figure 2.8, we notice that the profile using the fast CT
attenuation map in the Symbia/T6 reconstruction has a near perfect alignment and offers
similar correction with and without respiratory motion. The profile across the heart for
the slow CT attenuation map in the Infinia/Hawkeye-4 reconstruction (figure 2.7) shows
an over correction in counts when respiratory motion is present. This may be explained
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by referring to the CT scan seen in figure 2.6d, where motion in the slow CT acquisition
changes the attenuation coefficients to higher values which are similar to that of bone
due to the streaking artifacts causing the over correction in the SPECT reconstructed
image.
Concerning the impact of the fast and slow CT attenuation maps on SPECT
reconstructions, RMS errors were smaller and correlation coefficients were higher for the
fast CT compared to the slow CT, for all three canines. This effect was larger than what
was recorded in the averaged computer simulations. It is important to note that our
canine SPECT imaging was performed without respiratory gating, thus the impact of
mis-registration is averaged across all SPECT frames of the respiratory cycle. SPECT
data is acquired across tens of minutes and each projection is averaged across all frames
of the respiratory cycle. In the case of fast CT, data is acquired in seconds and in a single
frame of the respiratory cycle (breath-hold). In the case of slow CT, data is acquired in a
few minutes with the patient free breathing, thus projections are acquired in different
frames of the respiratory cycle. These differences lead to mis-registration errors between
SPECT and CT data and thus compromise attenuation correction. Perhaps one method
for addressing the challenge of mis-registration is to acquire gated CT (cine CT) and
gated SPECT, which has been proposed for PET/CT [53].

However, cine CT

acquisitions will substantially increase patient dose, while gated SPECT will lead to a
marked reduction in count density or lengthen SPECT acquisition time and increase
patient discomfort.
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2.4.3 Patient Motion in SPECT/CT
Patient motion is an important determinant in SPECT/CT image quality. In
cardiac imaging, two important aspects of motion arise from the beating heart and the
respiratory cycle. Our study focused on respiratory motion only, which is generally
larger in magnitude than cardiac motion [67]. For our computer phantom, we modelled a
breathing phantom with a non-beating heart, and simulated data acquisition using
respiratory-gated SPECT and CT, which is not standard clinical practice. For our canine
experiments, we once again only looked at respiratory motion and not cardiac motion.
This was necessary since only in a deceased canine could we control and arrest
completely the respiratory motion, which was required for the gold-standard in our
experimental design. The assessment of motion artifacts arising from a beating heart is
important, and future studies could examine this aspect via computer simulations. From
an experimental perspective, other groups are looking into the potential of respiratorycardiac double-gated SPECT [68].

2.4.4 Radiation Dose
One concern with SPECT/CT is the increased dose associated with the CT scan.
Radioisotope transmission imaging, the predecessor to CT in attenuation map
measurements, typically imparted a dose of a few μSv [69]. The typical radiation dose
experienced from a slow rotating CT such as the one used in the Infinia/Hawkeye-4, is
on the order of 0.5 mSv [70]. The radiation dose associated with a fast rotation CT such
as the design used in the Symbia/T6 is on the order of 2-4 mSv [71]. In addition to this
radiation dose, the radioisotope dose given to the patient for the SPECT portion must
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also be considered. For the purpose of a rest/stress myocardial perfusion SPECT scan
the radiation dose is approximately 12.5 mSv [71]. Thus, although the doses associated
with measuring attenuation maps are only 10-20% of those involved with SPECT, there
is a trend towards increasing dose as technology has progressed in attenuation maps
measurements.

2.5 CONCLUSION
This study compared slow-rotation and fast-rotation CT in their abilities to
facilitate non-uniform attenuation correction for myocardial perfusion cardiac
SPECT/CT. Both strategies for CT data acquisition were susceptible to artifacts induced
by breathing, and these artifacts compromised their ability to correct for attenuation.
Effects are most pronounced for attenuation maps, where they are even visually
apparent. Effects in SPECT reconstruction are more subtle, but can impact quantitative
analysis. Fundamentally, SPECT and CT data are acquired over very different time
frames relative to the respiratory cycle; thus fusing these two modalities will always
challenge registration and, in turn, attenuation correction.
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CHAPTER 3:

HYBRID SPECT/CARDIAC-GATED FIRST-PASS
PERFUSION CT: LOCATING TRANSPLANTED CELLS
RELATIVE TO INFARCTED MYOCARDIAL TARGETS

3.1 INTRODUCTION
The transplantation of stem cells for the purpose of treating heart disease is being
widely investigated [1].

To accurately evaluate the delivery and therapeutic

effectiveness of transplanted cell (TC) therapy sophisticated non-invasive techniques
must be established to visualize cell delivery, degree of retention, functionality, and longterm survival. Such techniques that afford the localization and quantification of TC
populations throughout early infarct evolution are of particular interest, and several
imaging techniques are under investigation [2, 3]. Magnetic Resonance Imaging (MRI)
of TCs using iron-oxide particles has shown promise in several animal studies [4, 5];
however, it is currently limited by low sensitivity and lack of specificity for intact, viable
cells [2, 6]. Despite this, delayed enhancement MRI does provide the most accurate
means of identifying infarct extent and location [7]. Positron Emission Tomography
(PET) can also be used to localize TCs with the use of

18

F-fluorodeoxyglucose (18F-

FDG) labeling, but is limited by the short half-life of the radioisotope [8] and rapid
clearance from labeled cells. Recently, it has been shown that cells may also be labeled
with

64

Cu-Pysuvaldehyde-Bis(N4-Methylthiosemicarbazone) (PTSM), allowing cells to

be followed for longer periods of time than with 18F-FDG. However, 64Cu is not readily
available and its half-life of 13-hours is still short for following cell lines over extended
periods [9].
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Hybrid imaging using Single Photon Emission Computed Tomography /
Computed Tomography (SPECT/CT), is a novel approach to the localization of TCs and
may be accomplished through the labeling of cells with
available than

111

In [10].

111

In is more readily

64

Cu and has a significantly longer half-life (2.8 days). We have shown

that this tracer can be used to follow transplanted bone marrow monocytes and
mesenchymal cells for a period of two weeks [11], making this technique highly
attractive for following TC populations. By combining this technique with concurrently
acquired CT (SPECT/CT), accurate spatial registration of these cells to anatomical
landmarks can be accomplished. However, it has recently been demonstrated that firstpass cardiac-gated CT can allow spatial localization of myocardial infarction, raising the
potential for a combined TC-infarct evaluation using this hybrid-imaging platform.
Delayed-enhancement (DE) imaging using CT has been recently explored,
mirroring the more established MRI technique used extensively in clinical practice [12,
13]. However, it has also been observed that first-pass cardiac CT imaging also initially
demonstrates hypo-enhancement in regions of myocardial infarction [14, 15]. These
regions have been shown to correlate well to areas of reduced perfusion using
Technetium (99mTc) perfusion imaging [16], and DE imaging with either MRI or CT and
likely represent the infarct core where micro-vascular blood flow is most severely
compromised [15, 17]. Such an evaluation for first-pass CT can be accomplished using
low-dose calcium scoring CT protocols with similar sensitivity to high-dose protocols
[18], which can be implemented in a commercial hybrid SPECT/CT system.
We previously described experiments involving

111

In radio-labeling of cells,

transplanting those radiolabeled cells and visualizing the distribution of the 111In hotspot
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using SPECT [11]. In that work, we saw that the background corrected signal intensity
of the hotspot decreases with time, and we proposed an in-depth model for explaining
this decrease [11]. That model proposes that some of the

111

In remains in the cells and

some washes out of the cells, and further, that some cells remain, and some die and/or are
removed from the injection site [11]. In this manuscript, we describe similar experiments
involving

111

In radio-labeling of cells and then characterizing the

111

In hotspot using

SPECT in terms of minimum detectable activity. We also evaluate the feasibility of
temporally and spatially localizing

111

In–labeled stem cells relative to infarcted

myocardium using a hybrid SPECT/[first-pass perfusion CT] imaging protocol.

3.2 METHODS
3.2.1 Validation of SPECT and CT Image Co-Registration
SPECT/CT was acquired using a standard clinical protocol (64 projections,
30s/projection, 128x128 image matrix) followed by a CT scan (17mAs, helical CT).
This was performed on two capillary tubes (1mm inner diameter) containing identical
mixtures of 300mgI/mL CT contrast (Omnipaque, General Electric Healthcare,
Waukesha, WI) and 50MBq 99mTc. These tubes were oriented in a ‘T’ pattern to measure
SPECT and CT co-registration in three axes.

Spatial alignment was evaluated by

comparing locations of tube centroids in SPECT and CT reconstructions.
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3.2.2 Animal Preparation
Canine studies were approved by the Animal Use Subcommittee of the University
of Western Ontario. Ten adult female mongrel hounds were used (typical weight: 20
kg). All canines underwent general anesthesia using propofol induction followed by
Isoflurane (1.5-2%) maintenance and mechanical ventilation. Subsequently, during open
thoracotomy, canines underwent surgical ligation of the left anterior descending (LAD)
coronary artery using a suture placed distal to the first diagonal branch. To provide a
representation of both non-reperfused and reperfused myocardial infarction, 4 dogs
underwent a permanent ligation of the LAD, while 6 had reperfusion after 2-hours by
releasing the ligature.

3.2.3 Cell Preparation
Peripheral blood was harvested from each canine and endothelial progenitor cells
(EPCs) were isolated using density gradient centrifugation with Ficoll-Paque PLUS
(General Electric, Waukesha, WI). Culture expansion took place over eight-weeks to
allow for cell expansion to thirty million cells, as previously described [19, 20]. Cells
were then labeled with

111

In (0.1 Bq/cell) by incubating them with

111

In-tropolone in

370C Hanks Balanced Salt Solution (HBSS) for 30 minutes [11, 19]. After washing three
times with HBSS, the labeled cells were suspended in HBSS in preparation for cell
delivery.
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3.2.4 Cell Transplantation
Stem cell delivery was performed epicardially and endocardially. Three canines
with epicardial injections received the transplanted cells on the day of infarction. These
10 canines were split into two groups consisting of chronic occlusions (1) and reperfused
occlusions (2). Endocardial injections were performed on 7 canines, with 4 out of 7
injections at 1-week post-infarction split evenly between chronic and reperfused cases
while the rest were performed on the day of infarction consisting of 2 reperfused
occlusions and 1 chronic occlusion (table 3.1).
TABLE 3.1: Summary of Transplantation Method

Dog
1

Arterial Status

Cell Injection Technique

Reperfused

Endocardial*

Reperfused
Epicardial*
Chronic
Epicardial*
Chronic
Endocardial†
Reperfused
Endocardial†
Chronic
Endocardial*
Reperfused
Endocardial*
Reperfused
Epicardial*
Reperfused
Endocardial†
Chronic
Endocardial†
* Injections performed on day of infarction
† Injections performed one-week post-infarction

2
3
4
5
6
7
8
9
10

3.2.5 Endocardial Injections
Following femoral cut-down and insertion of a 7-French introducer sheath, the
animal was transported to the angiography suite for cell injection. With the animal in a
supine position, separate right anterior (30º) and left anterior oblique (60º) contrast
ventriculograms (Omnipaque) were obtained using a 6-French pigtail catheter.
Endocardial injections were performed using the Stiletto™ Endomyocardial Injection
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System (Boston Scientific, Natick, MA) under X-ray fluoroscopic guidance. This system
uses a retractable 26 gauge needle which extends beyond its casing with a length of 3.5
mm. The Stilletto catheter is guided to the endocardium inside a 7-French guiding
catheter. The guiding catheter tip was advanced to the distal anterior segment of the left
ventricle until contact was made with the endocardium. The catheter has a radiopaque
marker, which allowed one to determine that the catheter is abutting perpendicular to the
endocardial wall.

With confirmation of endocardial contact, the Stilletto catheter was

advanced to the edge of the guiding catheter, and multiple (8-10) injections within a 1-2
cm diameter zone into the peri-infarct region were performed for each animal, using the
wall motion abnormalities seen on the contrast ventriculograms as a guide.

3.2.6 Epicardial Injections
For the epicardial approach, the cells were injected directly into the peri-infarct
region (confirmed by visual identification of discoloration and reduced regional wall
motion at the epicardial surface) at 8-10 sites within a 1-2 cm diameter zone using a 25gauge needle.

This was done in the same session as the infarction during the

thoracotomy.

3.2.7 SPECT/[First-Pass Perfusion CT] Imaging
The animals were transported while under anesthesia to the SPECT/CT suite 3040 minutes following stem cell injection, and SPECT/CT was acquired immediately
using a 6-slice SPECT/CT scanner (Symbia T6, Siemens Healthcare, Erlangen,
Germany). The initial SPECT scan consisted of 64-projections at 30s/projection, and a
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128x128 image matrix. This was followed by baseline pre-contrast CT at end expiration
[21], employing a 2.5mm slice thickness and in-plane resolution of 0.4x0.4mm (130kVP,
15mAs, 15 second acquisition time). A slice thickness of 2.5mm was chosen based upon
reduced voxel size requirements for myocardial imaging and to ensure full heart
coverage within a single breath hold. A 30mL bolus of 300mgI/mL Omnipaque was then
injected through a peripheral vein using a 30mL syringe by hand, with a cardiac-gated,
helical-CT performed 5 seconds post-bolus using a Calcium Scoring protocol (Current =
15mAs) [18,20]. On the Siemens Symbia T6 SPECT/CT the only method to perform a
gated-CT is to use the pre-defined Calcium Scoring acquisition sequence, which consists
of an ECG-gated helical-CT. All CT imaging was performed at end-expiration. Identical
follow-up SPECT/CT scans were performed in each of the canines at 4, and 10 days post
stem cell injection. An increase in the SPECT projection time per view was made for the
day 10 acquisitions to 120 seconds to partially compensate for the physical decay of 111In
and anticipated loss of signal due to reduction in cell density at the transplantation site
[11].

3.2.8 Dual-Isotope SPECT Imaging
Since SPECT has the capability to image two isotopes simultaneously, it is
possible to label cells with

111

In-tropolone as previously described, and inject

99m

Tc-

sestaMIBI for cardiac perfusion imaging. This was done for one canine experiment with
a reperfused occlusion and an endocardial injection strategy to compare this technique
with that of SPECT/[first-pass perfusion CT] imaging.

The same SPECT image

acquisition protocol was used as for the day of transplantation.
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3.2.9 Validation of First-Pass Perfusion CT using DE MRI
Two additional canines underwent contrast CT and DE MRI imaging on the same
day to validate infarct localization using the contrast CT technique. One canine had a
reperfused occlusion of the LAD 65 days prior to imaging with the other having a nonreperfused (chronic) ligation of the LAD 67 days prior to imaging. The animals were
anaesthetized and first-pass perfusion CT was performed using the previously described
technique. They were then directly transported to the MRI suite and had DE MRI
performed during the same anesthetic period (2 hours).
DE MRI was performed using a 3-Tesla MRI scanner (VERIO; Siemens
Healthcare, Erlangen, Germany) and a 8-element body matrix radiofrequency coil.
Cardiac gating was performed using a standard 3-lead system placed over the anterior
thorax.

Intravenous gadolinium (0.2 mmol/kg Gadobutrol (Gd-BT-DO3A), Bayer

Healthcare Pharmaceuticals) was administered by a peripheral vein and DE imaging
performed 15 minutes later. A phase-sensitive inversion recovery (PSIR) pulse-sequence
(with the inversion time adjusted in the standard fashion [22]) with matrix size 256 X
192 and slice thickness 6 mm, gap 2 mm was used. The slices were taken from the
atrioventricular annulus to the apex in the 4, 3 and 2-chamber views.
Infarct location was visually assessed on both the DE MRI images and first-pass
perfusion CT images by an experienced investigator [JW].

The presence and

transmurality (0 to 100%) of contrast-enhancement (MRI) and hypo-enhancement (CT)
was recorded for each myocardial segment using the AHA 17-segment model [23].
Corresponding segmental scores were then compared between the 2 techniques.
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3.2.10 Contrast-to-noise ratio (CNR) Calculations
111

In SPECT images were corrected for background activity and reconstructed

using Ordered Subset Expectation Maximization (OS-EM) (3 iterations, 16 subsets) [24].
Contrast-to-noise ratio (CNR) was calculated for all the imaging sessions (10 canines, 3
imaging sessions each). CNR calculations were done by choosing an
interest (VOI) for each reconstruction. The

111

In volume-of-

111

In VOI was defined to be the pixels

greater than 10% of the maximum pixel value in the 111In SPECT reconstruction [25] for
each imaging session. Therefore, the

111

In VOI was different for each imaging session

depending on the maximum pixel value for each particular

111

In SPECT reconstruction.

The background activity for each session was taken to be 26 VOIs, each VOI being the
same size as the

111

In VOI for that particular session and directly adjacent to the

111

In

VOI [25]. This was performed for each imaging session. The CNR for each session was
calculated using the following equation [25]:
CNR =

111

In signal − background
SD (background )

(3.1)

Where 111In signal was equal to the sum of the counts in the 111In VOI, background is the
mean of the sum of the counts in each of the 26 background VOIs, and SD(background)
is the standard deviation of the sum of the counts inside each of the 26 background VOIs.

3.3 RESULTS
3.3.1 Validation of SPECT and CT Image Co-Registration
A reconstructed isotropic resolution of 11.5mm was observed in the SPECT, and
5.9mm in the CT. Once data is removed from the acquisition system, the SPECT data is
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registered to the CT attenuation map, which is a down-sampled version of the highresolution CT; hence the lower CT resolution. Centroid measurements indicated minimal
co-registration error between SPECT and CT data. These measured 1.63mm, 0.24mm,
and 1.34mm in the anterior-posterior, left-right, and apical-caudal directions, respectively
(See Figure 3.1).

Figure 3.1: SPECT and CT registration
Images displaying both SPECT (RED) and CT (GREEN) reconstructions in the
trans-axial (upper image) and the sagital (lower image) planes. The patient table is only
CT visible, while the capillary tube phantom is imaged by both SPECT and CT. Notice
the near perfect registration between the SPECT and CT (YELLOW).
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Canine Infarct Validation Study
All 10 animals completed the study. Examples of both endocardial and epicardial
injections are shown in Figures 3.2 and 3.3 respectively.

3.3.2 SPECT/[First-Pass Perfusion CT] Imaging
Baseline SPECT images on the day of cell transplantation demonstrated increased
signal in the anterior left ventricular apex in all animals. The 111In-labeling technique was
successful in allowing residual signal from retained cells to be visualized for at least 10
days in all animals.
Ten out of 10 (consisting of 30 imaging studies) of the simultaneously acquired
first-pass perfusion CT datasets demonstrated regional hypo-enhancement in the distal
anterior segments of the left ventricle, consistent with LAD coronary artery vascular
distribution.
Fusion of baseline SPECT and first-pass perfusion CT images was successful in
all canines.

Examples of image fusion are shown in Figures 3.2 and 3.3, each

demonstrating successful identification of transplanted stem cells within regions of hypoperfused myocardium.

The location of both the cells and zone of hypo-perfusion

(infarction) were clearly visualized on the day of injection, and at all follow-up time
points (Figures 3.2 and 3.3). A distinct boundary separating normally perfused vs.
reduced flow regions was clearly seen on first-pass perfusion CT studies in all of the
imaging studies performed. The 111In focus was visualized consistently at least up to 10
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days post cell transplantation, despite a low 111In count rate on day 10 for every animal.
For all canines and all imaging sessions, the center of the 111In focus was located within
the infarct boundary.
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Figure 3.2
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Figure 3.2: Endocardial injection of cells seen on SPECT/[first-pass perfusion CT]
(A) Imaging session on day 0 of endocardial injection (Dog 5: endocardial cell injection
1 week post reperfused occlusion). Top row: Contrast enhanced CT image displaying
region of infarction (hypo-enhancement) at the left ventricular apex and extending into
the lateral wall. Bottom row: First-pass perfusion CT fused with SPECT displaying
location of 111In labeled stem cells near region of infarct. The labeled cells are localized
on the inner wall of the left ventricle confirming an endocardial injection.
(B) Day 4 follow-up images taken 4 days post cell transplantation. We notice a weaker
signal coming from the cells due to both the physical half-life decay of

111

In and

clearance of cells from the injection site.
(C) Images acquired 10 days post cell transplantation. Cellular signal is still weak, but a
longer imaging session partially compensated for the loss of signal. As well, the area of
hypoperfusion seen on CT appears to be both smaller and the contrast between it and
normally perfused myocardium is not as marked as on day 0, 1 week post infarct.

85

Figure 3.3
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Figure 3.3: Epicardial injection of cells seen on SPECT/[first-pass perfusion CT]
Imaging session on day 0 of epicardial injection (Dog 3: epicardial injection on day of
chronic occlusion).

Top row: Contrast enhanced CT image displaying region of

infarction (hypo-enhancement) at the left ventricular apex and extending into the lateral
wall. Since this was a sustained occlusion the infarct can be seen much more clearly than
in the animals with reperfusion injury as shown in fig 3.2. Bottom row: First-pass
perfusion CT fused with SPECT displaying location of

111

In labeled stem cells near

region of infarct. The labeled cells were localized on the outer wall of the left ventricle
confirming an epicardial injection for this case.
(B) Day 4 follow-up images taken 4 days post cell transplantation.
(C) Day 10 follow-up images acquired 10 days post cell transplantation.

First-pass perfusion CT outlines reduced blood flow, and his region decreased in
extent over time from the day of transplantation through to 10 days afterwards. We
hypothesize that this is due to augmented collateral flow into the initially hypo-perfused
regions in this canine model, with progressive improvement in blood flow into the periinfarct region. Another explanation for the reduced zone of hypo-enhancement could be
that infarct size shrinks over time [26, 27] due to remodeling of the evolving scar.
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3.3.3 Dual-Isotope SPECT Imaging
Figure 3.4 compares a dual-isotope SPECT acquisition, with that of
SPECT/[First-Pass Perfusion CT]. In dual-isotope SPECT imaging
the cardiac perfusion image while the

99m

Tc-MIBI shows

111

In-tropolone displays the location of the cells

that were injected. The spatial resolution was not sufficient to distinguish whether these
cells were injected epicardially or endocardially. In addition, it is also more difficult to
clearly delineate the zone of reduced blood flow in the cardiac perfusion image using
99m

Tc-MIBI. However, using the SPECT/[first-pass perfusion CT] technique the infarct

zone was clearly delineated and the location of the cells were located on the inner wall of
the left ventricle confirming an endocardial injection.

88

Figure 3.4: Comparing SPECT/[first-pass perfusion CT] with dual isotope SPECT
Case example of endocardial injection of stem cells in a canine model performed 44 days
post infarction (reperfused).
perfusion CT (top left) and

Cardiac perfusion images performed using first-pass
99m

Tc-MIBI (top right), demonstrating a region of hypo-

perfusion consistent with the infarction territory (arrows). Fused stem cell / perfusion
imaging shown using SPECT 111In-tropolone /[First-Pass Perfusion CT] imaging (bottom
left) and dual-isotope 99mTc-MIBI / 111In-tropolone SPECT imaging (bottom right). The
improved spatial resolution of the first pass CT perfusion-based fusion image permits a
clearer recognition of stem cell delivery to the endocardial border of the myocardial
infarction, and the trans-mural immediate contrast provides information regarding the
micro flow environment in the region of the transplanted cells.
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3.3.4 Validation of First-Pass Perfusion CT using DE MRI
Two canines successfully underwent both first-pass perfusion CT and DE MRI
following surgical ligation of the LAD. The reperfused dog had CT hypo-enhancement
scored in segments 13 and 14 with transmurality scored at 0-25% and 25-50%,
respectively. The corresponding DE MRI images were scored to have enhancement in
the same segments with transmurality scores of 25-50% and 50-75%, respectively
(Figure 3.5). The non-reperfused (chronic occlusion) dog was scored to have CT hypoenhancement in segments 7, 13, 14 and 17 of the AHA segmental model, corresponding
to the mid anterior, distal anterior, distal septal and apical segments. The transmurality
scores for each segment were 25-50% for segment 7, 50-75% for segments 13 and 14 ,
and 75-100% for segment 17.

The corresponding assessment by MRI confirmed

enhancement in precisely the same segments with transmurality scores of 50-75% for
segment 7 and 75-100% for all remaining segments. (Figure 3.6).
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Figure 3.5: Comparing first-pass perfusion CT with delayed-enhanced MRI
Comparison of Contrast enhanced CT (left panel) and delayed enhanced MRI in a dog
with a reperfused infarct (Dog 7). Once again, the degree of reduced signal is not as
great on CT as is the degree of increased signal seen on the MR images but the smaller
area of reduced perfusion in this subendocardial infarct can be identified. The CT hypoenhancement scores in segments 13 and 14 of the AHA segmental model had
transmurality scores of 1 and 2 out of 4, respectively. The corresponding MRI images
were scored to have enhancement in the same segments with transmurality scores of 2
and 3 out of 4 respectively, respectively.
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Figure 3.6: Comparing first-pass perfusion CT with delayed-enhanced MRI
Comparison of Contrast enhanced CT (left panel) and delayed enhanced MRI (right
panel) in a dog with a chronic occlusion infarct (Dog 4). The degree of reduced signal in
the infarct region on the CT images is less than the degree of increased signal seen in the
MR image but the hypo-enhanced region is clearly seen (arrows).

The CT hypo-

enhancement in segments 7, 13, 14 and 17 of the AHA segmental model had
transmurality scores of 2, 3, 3 and 3 out of 4, respectively.

The corresponding

assessment by MRI confirmed enhancement in the same segments with transmurality
scores of 3, 4, 4 and 4 out of 4, respectively.
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3.3.5 Contrast-to-noise ratio (CNR) Calculations:
The mean and standard error of the mean (SEM) of the natural log of CNR for all
10 canine experiments are shown in figure 3.7. For all imaging sessions the CNR was
well above the accepted minimum CNR criterion of 4 (i.e. Rose Criterion [28]). Note
that the CNR drops from day 0 to day 4, and then remains relatively unchanged going
from day 4 to day 10.

Figure 3.7: CNR analysis
Plot of the average of the natural logarithm of the CNR for 10 dog experiments imaged
on day of transplantation of canine endothelial progenitor cells and then at 4 days and 10
days later. Error bars correspond to the SEM. The dashed line near the bottom of the plot
corresponds to the Rose criterion, the minimum CNR for a signal to be detectable, i.e.
CNR=4. SPECT data acquisition time was increased four times on day 10 which reduced
the expected drop in CNR as the effective half life of the 111In loss was 2 days. Note that
a natural log (CNR) of 6.0 corresponds to a CNR of approximately 400.
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3.4 DISCUSSION
This study is the first to demonstrate the feasibility of temporally and spatially
localizing TC populations over a 10-day period relative to infarct tissue using a
commercially available hybrid SPECT/contrast-CT imaging approach.
A central challenge for the field of cell therapy is the capability to document and
monitor TC populations relative to the injured tissue. There continues to be debate with
respect to optimal delivery sites relative to recently infarcted tissue. If cells are delivered
to the infarct core the marked reduction in perfusion, associated hypoxia, and oxygen
free radicals may compromise myocardial regeneration. In contrast, cells placed towards
the periphery of infarcted tissue are more likely to produce a therapeutic effect,
presumably due to a less hostile environment [29]. While this hypothesis requires further
validation, the use of first-pass perfusion CT imaging provides an appropriate means for
a qualitative evaluation of myocardial blood flow. Delayed imaging techniques, while
attractive for the accurate delineation of full infarct extent, are not appropriate, as they do
not define compromised flow within the infarct region. By aiming to deliver stem cells
immediately adjacent to, but not within the hypo-perfused infarct core optimal
survivability may be obtained.

3.4.1 SPECT/[First-Pass Perfusion CT] in Cellular Imaging
In this study, we report on the use of CT hypo-enhancement following bolus
administration of contrast to identify the region of reduced flow. Nieman, et al [12]
demonstrated in patients that the extent of this hypo-perfused zone correlates well with
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regions of contrast enhancement using contrast-CT or DE MRI, the latter of which is
validated for measuring the extent of infarction [7]. In this study, it was confirmed that
the hypo-enhanced site detected by CT is within the infarct boundary as determined by
DE MRI. In the two animals, the transmural extent of the zone of hypo-enhancement
was smaller on CT imaging than the zone of enhancement on MRI, consistent with this
representing the infarct core where myocardial blood flow is most diminished [17].
SPECT/contrast-CT demonstrated very good registration accuracy (~1mm) using
phantom experiments. However, these experiments were performed on a non-moving
phantom. Visual inspection of the in vivo canine fused SPECT/contrast-CT images was
performed by an experienced investigator [GW] and the injection strategy was
determined 70% of the time. Therefore, cells injected in outer wall (epicardial injection)
could be distinguished from those injected in the inner wall (endocardial injection). This
implies that the registration accuracy is still sufficient even during in-vivo imaging.

3.4.2 Hybrid Imaging for Cell Localization
This study introduces another application for CT in hybrid SPECT/CT. CT can
be used to provide spatial localization of myocardial infarction in addition to providing
general anatomic localization and SPECT attenuation correction. Stodilka et al [30] have
shown that a high-resolution CT signal can improve the ability to localize and quantify a
relatively weak SPECT signal with low-resolution. Thus we expect that, in the case of
cell transplantation, as the SPECT signal decays over time due to physical decay and/or
washout of cells, the CT can be used to aid in SPECT quantification. It is true that
SPECT can be used to image multiple isotopes and 99mTc perfusion imaging may be used
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instead of CT perfusion to locate regions of reduce blood flow. However, relying upon
SPECT alone would not provide sufficient spatial resolution to clearly delineate the zone
of reduced blood flow as well as the co-registered contrast-CT. Additionally, the use of
111

In requires imaging with a medium energy collimator, which will further reduce the

spatial resolution of the 99mTc perfusion SPECT scan.
It could be argued that the introduction of PET/MRI would replace this
application of SPECT/CT, given the increased sensitivity of PET and the reduction of
ionizing radiation [31]. To-date the preferred PET isotope for cell localization is

64

Cu

[9]. 3D-PET with 64Cu has approximately a 20-fold greater sensitivity than SPECT with
111

In; however, this advantage is lost by a two week time period due to physical half-life

differences [32]. Interestingly evidence to date suggest that the limits of radio-label in
Bq/cell are similar for

64

111

Cu [9] and

In [25], hence increasing the sensitivity of

64

Cu/PET by increasing the 64Cu load per cell is not an option.

3.4.3 Contrast-to-Noise Ratio
This average CNR curve (figure 7) can be used to predict how far out
transplanted cells can be followed.

111

In labeled canine EPCs have been shown to have

an approximate effective half-life of 2 days (combining both biological and physical
decay of

111

In [11, 20]). The average CNR decreases from day 0 to day 4. Since

imaging time was constant from day 0 to day 4 a decrease in CNR is expected due to the
physical and biological decay of the

111

In labeled cells. However, the change in CNR

from day 0 to day 4 is less than expected for an effective half-life of two days. The
signal in the 111In VOI does decrease with a 2-day half-life; however, the background and
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the SD of background are significantly lower at 4 days increasing the CNR [25]. The
background is higher at day 0 as within hours following cell transplantation a significant
fraction of the cells leave the transplantation site. These cells have a biological half-life
in the region surrounding the transplant site of approximately 20 hours [11]. Hence, by
day 4 they are mostly cleared resulting in the observed reduction in background, and SD
of background resulting in increasing the CNR. After day 4, the background activity and
SD of background activity remains constant, and the change in CNR from day 4 to day
10 has undergone decay from 3 half lives. However, imaging time was increased by a
factor of 4, which compensated for approximately half of the decay. If we maintain a
consistent imaging time after day 10, we would theoretically be capable of imaging
transplanted cells for a period of 22 days (i.e. 11 two day effective half-lives), before the
CNR drops below the Rose Criterion provided the background and SD of background do
not increase. This trend is similar to cardiac chest phantom experiments conducted by
Jin et al [25]. However, to properly image TCs up to 22 days, the cell location must be
known beforehand, and this can be accomplished with the aid of CT imaging [25, 30].

3.4.4 Risk to Patient
For the case of our CT imaging, the dose is relatively low, with a computed
tomography dose index volume (CTDIvol) of 3.9 mGy. With the settings used on our
CT scanner this would produce an effective radiation dose to the patient of around
0.7mSv [33]. This radiation dose would produce a cancer rate of 5.6 x 10-5, while the
spontaneous cancer rate for a general population is 8.4 x 10-1 [34]. The risk associated
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with CT contrast agents similar to the one used in this study is nephrotoxicity (renal
toxicity), which has a prevalence in the general population of 0.9% [35].

3.4.5 Study Limitations
The SPECT/CT registration experiment was performed on a non-moving
phantom. We chose to use a breath-hold CT acquisition at end-expiration for the canine
experiments since recent clinical trials have shown this to be the optimal phase of the
respiratory cycle for best image registration in SPECT/CT for the purpose of attenuation
correction [21]. We recognize that the SPECT and CT data were not acquired under
identical conditions since the SPECT data is averaged over multiple respiratory phases in
a step and shoot manner, while the CT data was collected in a continuous rotation during
a single phase of the respiratory cycle [36]. This is a challenge in hybrid SPECT/CT
imaging; not only for image fusion but also for attenuation correction and this should be
addressed in more detail in a future study.

In our experiments, the animals were

ventilated, and the CT data acquisition occurred at the end-expiration phase of the
respiratory cycle. They were ventilated at a rate of 8 breaths per minute, and for 70% of
the respiratory cycle the canines were at functional residual capacity (FRC). Therefore,
we expect the SPECT data to be averaged more closely to the end-expiration phase of the
respiratory cycle and hence the end-expiration CT that was acquired. Application to
patients is expected to be straightforward. Provided the patients can hold their breath
during the CT acquisition for 15 seconds at FRC and can maintain normal tidal breathing
during the SPECT portion.
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The canines were not sacrificed, and were used in subsequent experiments;
therefore, no follow-ups were conducted on the canines post-mortem to determine the
effects of the cell transplantation. A previous study in our lab used this technique to
compare the survival of the cells following the two injection strategies [20].

3.5 CONCLUSIONS
This study demonstrates the feasibility of hybrid SPECT/first pass perfusion CT
imaging for the spatial localization of transplanted stem cells relative to infarcted
myocardial tissue. The combination of a diagnostic quality CT on the hybrid platform
allows the determination of the

111

In signal with transmural resolution, which is not

possible using multi-spectral SPECT methods.
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CHAPTER 4:

SMALL FIELD-OF-VIEW CARDIAC SPECT CAN BE
IMPLEMENTED ON HYBRID SPECT/CT PLATFORMS
WHEREIN DATA ACQUISITION AND
RECONSTRUCTION ARE GUIDED BY CT 1

4.1 INTRODUCTION
Image truncation in nuclear medicine is an increasing problem.

Current

reconstruction techniques introduce errors into the image if the activity distribution
extends beyond the detector field-of-view (FOV) [1].

Truncation in Single Photon

Emission Computed Tomography (SPECT) can arise from several different reasons. The
first can be the natural evolution to improve SPECT detectors to incorporate more
expensive solid-state technology and reducing field-of-view (FOV); secondly, data
acquisition of large patients can cause the projections to be truncated; and lastly, the use
of converging collimator geometries in SPECT.
Solid-state detectors may achieve better energy and spatial resolution as well as
enhance image contrast [2, 3]. Solid-state detectors demonstrated visual superiority and
improved quantitative accuracy for SPECT compared with Anger type cameras [4].
However, the primary detractor to the acceptance of solid-state technology is high cost
both for raw material and fabrication. Consequently, in an effort to reduce cost, several
groups have explored the concept of using small detectors [5, 6].

The challenge

associated with reduced detector size is object truncation.
Data acquisition of large patients also produces object truncation in reconstructed
images.
1

Lalush and Tsui [1] evaluated the MLEM iterative algorithm [7] and its

The contents of this chapter have been published as: Sabondjian E, Stodilka RZ, Belhocine T, King ME,
Wisenberg G, Prato FS. Small field-of-view cardiac SPECT can be implemented on hybrid SPECT/CT platforms
where data acquisition and reconstruction are guided by CT. Nuclear Medicine Communications 2009;30(9):718-726.
It is reproduced with permission from the publishers.
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accelerated derivatives, OS-EM [8] and RBI-EM [9] under circumstances of extreme
truncation using the MCAT digital phantom. They suggested a simple modification to
the algorithm to substantially reduce truncation, but concluded that extreme truncation
had to be avoided.
Finally, truncation also occurs when performing SPECT with converging
collimators [5]. Gullberg et al [10] introduced a reconstruction algorithm to correct for
ring artifacts from image truncation when performing cone beam tomography of the
heart. Zeng et al [11, 12] discuss the use of fan-beam and cone-beam collimators with
varying focal lengths to minimize the effects of truncation.

A new reconstruction

algorithm was developed for such a collimator and has shown promise in reducing
truncation artifacts.

Chang et al [5] proposed a method for local SPECT using a

cylindrically-arranged array of small gamma cameras whose FOVs are focused onto a
13.5 – 18.5 cm diameter central region-of-interest (ROI), sacrificing adequate sampling
over the object periphery for improved sensitivity in the central ROI. In a subsequent
paper, the group hypothesized that the severity of artifacts is related to the amount of
radiotracer present outside the central ROI, and used computer simulations to show
errors of approximately 4-10% with a 99mTc-MIBI tracer when comparing truncated data
to non-truncated data [9].
Many authors have studied truncation artifact reduction in radioisotope emission
[5, 13] and transmission imaging [14, 15, 16, 17, 18]. Additionally, Defrise et al [19]
present a theoretical analysis for reconstructing a small ROI from highly truncated data.
Many of the techniques for reduction of transmission artifacts rely on a priori knowledge
of the body contour, and their accuracy improves with the accuracy of the measured body
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contour [20]. Given that solid-state detectors may be clinically realized in the context of
hybrid SPECT/CT [21], and SPECT/CT is gaining popularity without increasing patient
dose to unacceptable levels [22], we anticipate that a likely imaging scenario will involve
the coupling of severely truncated SPECT data and non-truncated CT. In this case, a
priori knowledge of the body contour available via CT may be useful in helping
reconstruct a truncated SPECT data set.
In this paper, we investigate the concept of SPECT/CT assuming highly truncated
SPECT as might be expected when using small FOV detectors or converging geometries,
in conjunction with a non-truncated CT. Tomographic sampling is characterized using
the concept of crosstalk, introduced by Gifford and Barrett [23].

Additionally, we

investigate a simple modification to the OS-EM algorithm that significantly reduces
artifacts when the object contour is known, which may be obtained from CT. The
modified algorithm was previously evaluated in canine studies [24]; in this paper we
demonstrate its application in a cardiac chest phantom and a series of 14 clinical cardiac
patients [25]. The modified algorithm is evaluated by comparing its performance using
truncated data with the performance of standard OS-EM using non-truncated data. The
comparison is in terms of: relative quantification both for large regions-of-interest and
individual voxels, as well as impact on defect size.
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4.2 METHODS
4.2.1 Proposed System
Figure 4.1 is an example of a system that incorporates a small FOV gamma
camera. In this system, the X-ray CT is acquired first and reconstructed. The operator
then positions onto the X-ray CT image a circular ROI (cylindrical across multiple transaxial slices) delineating the scanning area where SPECT measurements are to be
obtained. The diameter of the ROI is determined by the gamma camera FOV in the
transaxial plane which, for the purpose of the present study, is taken to be 16cm. The
position of the ROI determines the trajectory of the gamma camera, which is constrained
by the requirement to always face the ROI throughout its orbit. The orbit may include
tangential translation in the transaxial plane if the center of the ROI is not coincident
with the X-ray CT FOV center. The gamma camera is then tasked to acquire its data. A
similar approach has been demonstrated by Rahmim et al [26], which incorporated a
converging collimator design.

Figure 4.1: The proposed system
Side and front views of the proposed small FOV SPECT/CT system. The right figure is
an example of the SPECT/CT acquisition that would be achievable.
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4.2.2 Sampling Theory
The forward imaging problem can be expressed as Y = AX, where Y is the
projection data wherein gamma ray measurements are binned to provide counts yt in
sinogram element t; A is the transition matrix comprised of elements atj representing the
probability that an emission from voxel j is recorded at t, and X is the radiotracer
distribution comprised of elements xj.
In reducing the size of the FOV, the sampling pattern will be altered drastically,
leading to changes in sensitivity and resolution. To characterize these changes, we used
the cross-talk concept, originally developed by Gifford and Barrett [23] to study
sampling patterns in the Fourier domain. Following [27] we adapt this concept to the
spatial domain. The spatial cross-talk matrix is defined as [27]: H = ATA, where T
indicates matrix transpose. The diagonal elements of H represent the sensitivity of the
sampling pattern to any voxel, and rows of H represent the degree of aliasing between
any two voxels resulting from inadequate sampling.
For the purpose of calculating H, we used a simplified transition matrix derived
from a radon transform of a single slice, without modeling attenuation, scatter, or
detector response to isolate the characteristics of tomographic sampling. The radon
transform of the single slice was modeled in accordance with our experimental data
acquisition, described in the following section.

4.2.3 Image Reconstruction
Our phantom and patient data were acquired on a two head Infinia-Hawkeye-4
slice (General Electric Healthcare, Waukesha WI, USA).

Data was sampled
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tomographically over 120 uniformly spaced projections (60 steps per head). The original
34x34cm FOV gamma camera projections were truncated to simulate a small 16x16cm
FOV gamma camera acquisition, where the orbit was selected to focus on the heart.
Examples of a complete FOV and a truncated FOV sinogram are shown in figure 4.2 for
a clinical 99mTc-MIBI scan. The size of the SPECT sinogram matrix is chosen as if a full
FOV gamma camera is being used; this representation illustrates clearly the truncated
locations.

A typical human chest is approximately 30cm across, therefore as

demonstrated in figure 4.2 a large portion of the data will be truncated.

Figure 4.2: Displaying truncated projection data
(A) Complete FOV sinogram. (B) Truncated sinogram to simulate small gamma camera.

The ROI, delineated on the X-ray CT as previously described, is then re-sampled
to the SPECT coordinate frame and projected into an empty matrix such that the spatial
and angular coordinates of the projection pixels have a one-to-one correspondence with
coordinates of the SPECT sinogram matrix. The sinogram of the ROI is then thresholded
to create a binary mask, which demarcates coordinates within the ROI where gamma
camera measurements were acquired (binary value of 0), and coordinates outside of the
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ROI, which are also beyond the FOV of the gamma camera (binary value of 1). SPECT
data is then reconstructed using the OS-EM algorithm of Hudson and Larkin [8],
modified slightly to explicitly show truncated regions in the SPECT sinogram matrix.
The modified OS-EM algorithm can be written in two parts as:
Forward projector:

J

μ = ∑ atj x kj
k
t

j =1

,

(4.1)

Back-projector and update:

x kj +1

⎛ k
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(4.2)

where gamma-ray measurements are binned to provide counts yt in sinogram elements t;
the expected number of gamma-ray emissions from voxel j is denoted by xj, with its
estimate after the kth iteration denoted as xjk. The elements atj represent the probability
that an emission from voxel j is recorded at t; which is derived from a model of gammaray propagation through tissue, which in the present case included non-uniform
attenuation.

Sn denotes a subset of the sinogram elements grouped into those

corresponding to a set of gamma camera gantry positions. The final factor in square
brackets in equation (4.2) includes the mask vector with elements mt corresponding to
elements of the measured sinogram yt. For all mt = 0, this factor reduces to the ratio of
measured and re-projected data (i.e. yt/μtk). In this case equations (4.1) and (4.2) together
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reduce to the well-known OS-EM algorithm. For all mt = 1, the final factor reduces to
unity. In other words, when mt = 1, the corresponding xj’s are not updated. The reprojected data is considered unmeasured [1], rather than measured as 0 (as in regular OSEM). Theoretically, the truly correct way to model truncation is to set appropriate terms
in the transition matrix ‘A’ to zero; however, this is already known [1] and results in
artifacts under conditions of extreme truncation [1]. The algorithm is initialized using a
priori knowledge of the object support, available from X-ray CT. Thus, the X-ray CT
reconstruction is re-sampled to the SPECT voxel coordinate frame, the patient table is
deleted; and all xj0 (i.e. 0th iteration) are set to 1 within the object support, and to 0
otherwise.

4.2.4 Phantom Study
An anthropomorphic torso phantom (model ECT/TOR/P, Data Spectrum Corp.,
Hillsborough NC, USA) was filled with 444MBq of

99m

Tc. The cardiac insert with the

standard defects supplied were placed in the apex and septal wall of the left ventrical.
The activity ratios in heart: soft tissue: liver were set to 7: 1: 3, where the ratios were
determined from SPECT/CT clinical scans at our center. The acquisition time was set so
that 10,000 counts/projection was recorded in the first projection, which is typical and
was generally observed in clinical cardiac rest scans.
The data was reconstructed in three different ways: (1) Using non-truncated data and
standard reconstruction (gold standard - NTOSEM).
standard reconstruction (TOSEM).
reconstruction (TMOSEM)

(2) Using truncated data and

(3) Using truncated data and the modified
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4.2.5 Clinical Study
In addition to the phantom study, we evaluated our method in a series of fourteen
patients (8 male, 6 female, mean age = 65 +/- 13 years, mean BMI = 32 +/- 5) who
underwent SPECT/CT myocardial perfusion imaging (MPI) under a rest/stress 1-day
protocol. For this paper we analyzed the rest SPECT/CT studies, which were performed
on patients 45 minutes after an injection of approximately 370MBq of

99m

Tc-MIBI.

Among the patient group, 8 patients had a definitely normal study and 6 patients had a
definitely abnormal study after SPECT/CT - MPI using the QGS/QPS software (CedarsSinai Medical Center, Los Angeles, CA, USA).

4.2.6 Image Analysis
Voxel-by-Voxel Analysis
Performance of the modified OS-EM algorithm was evaluated on a voxel-byvoxel basis.

This was done by calculating the Pearson correlation coefficient for

TOSEM vs NTOSEM; and TMOSEM vs NTOSEM, for each patient and the phantom,
for voxels within the reconstructed region of interest (ROI). We report the mean ±
standard deviation of the correlation coefficients for the group of patient data. Also, we
include example difference images and scatter plots showing the voxel-by-voxel
relationship between TOSEM vs NTOSEM; and TMOSEM vs NTOSEM. Calculations
were performed using MATLAB (The MathWorks, Natick, Massachusetts, USA). To
determine the impact of activity outside the reconstructed ROI on correlation
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coefficients: we calculate the ratio of activity within the reconstructed ROI to activity
outside the reconstructed ROI, and compared this ratio with the correlation coefficients.
Count Ratios
The cardiac images were aligned manually into standard orientations and a
central coronal slice of the heart was chosen by an experienced operator [T.B.]. Three
ROIs were drawn: (A) Apex, (B) Lateral Wall, and (C) Septal Wall of the left ventricle
(see figure 4.4). Each ROI was circular and had a diameter of 2cm. The location of the
ROIs were consistent for each patient. Ratios were calculated (A/B, B/C, and A/C) for
each reconstruction: NTOSEM, TOSEM, and TMOSEM. For each ratio the percent
error, equation (4.3), was calculated and averaged for each patient.

Ratio(Truncated ) − Ratio(Gold )
Ratio(Gold )

× 100 = Percent Error,

(4.3)

Ratios of normal and abnormal myocardium were both used. The goal of the
analysis was not to study the actual ratio value, but rather to compare the ratios of the
truncated projections to that of the gold standard.
Defect Size Comparison
The resting defect size was determined by the thresholding technique [28], using
a cutoff of 2.5 standard deviations below the mean of a group of normal patients to
define the perfusion defect. The defect size was determined using an in-house program.
The size of the defect within the whole heart seen in the two truncated reconstructions
(TOSEM, TMOSEM) was compared to that of the gold standard (NTOSEM) giving a
relative percent error.
Defect (Truncated ) − Defect (Gold )
× 100 = Relative %Error,
Defect (Gold )

(4.4)
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4.3 RESULTS
4.3.1 Sampling Theory
The diagonal elements of the crosstalk matrix (H) can be sorted into an image to
visualize sensitivity (see Fig 4.3A). For the case of the truncated FOV, the sensitivity
within the ROI varied by -/+1%; indicating that sensitivity is relatively uniform in this
region. This is also illustrated quantitatively in Fig 4.3D which is a profile across the ROI
from Fig 4.3A. The rows of H can also be sorted into an image showing the aliasing
between voxels as shown in Figure 4.3B.
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Figure 4.3: The sampling theory for large and small FOV gamma camera imaging
Top row is for truncated FOV, bottom row is for non-truncated FOV. Diagonal elements
of H sorted into an image to visualize sensitivity across a transaxial plane (A, E). The
circular region represents the region of interest (ROI), with a diameter equal to the
gamma camera FOV, where sensitivity is maximized. Rows of H sorted into an image
showing aliasing from a voxel within the ROI into nearby voxels (B, C, F, G). Image (B)
shows a relatively isotropic point-spread function with little aliasing. Image (C) shows
aliasing from a voxel beyond the ROI into nearby voxels, showing considerable
anisotropic aliasing. Together (B) and (C) indicate spatially variant resolution when the
FOV is small. Profiles across the dashed lines at the center of the sensitivity plots (D,
H). This demonstrates that sensitivity does not change going from small FOV to larger
FOV gamma cameras in the ROI.
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4.3.2 Clinical Study
Figure 4.4 displays three clinical acquisitions and one phantom acquisition.

All

examples are reconstructions of a region of interest (ROI) around the heart with transaxial slices being displayed.
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Figure 4.4: Clinical and phantom results
Diagram displaying location of ROIs chosen for ratio analysis shown on top. Left
ventricle displayed for three clinical patients and the phantom study (trans-axial view).
Hot rim artifacts are seen when using TOSEM (shown with arrow in scan #1). Scan #3
had a significant perfusion defect, which becomes obscured when using TOSEM. In
general, observation of the ROI around the heart shows the loss of cardiac signal with
TOSEM; however, the signal is properly recovered when using TMOSEM.
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4.3.3 Image Analysis
Figure 4.5 shows scatter plots of the reconstructed counts with the heart that are
associated with clinical scan #1 and scan #2 in figure 4 when compared to NTOSEM.
For clinical scan #1, comparing TMOSEM with NTOSEM, the correlation coefficient
was found to be 0.996; whereas when comparing TOSEM with NTOSEM, the
correlation coefficient was found to be 0.734.

On average for the 14 patients the

correlation coefficient was 0.991 -/+0.008 when comparing TMOSEM with NTOSEM,
and 0.609 -/+0.130 when comparing TOSEM with NTOSEM.

The correlation

coefficients for the phantom study were 0.999 and 0.996 when comparing TMOSEM and
TOSEM with NTOSEM, respectively.
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Figure 4.5: Scatter plots
Difference images and scatter plot showing the voxel-by-voxel correlation between
TMOSEM and NTOSEM as well as TOSEM and NTOSEM for clinical scan #1 and scan
#2 in figure 4, and the phantom study. The difference images and scatter plots only
consider the counts within the reconstructed ROI.
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The similarity in correlation coefficients for the phantom study may be related to
the phantom having a higher ratio of activity within the reconstructed ROI to activity
outside the reconstructed ROI, compared with the same ratio in clinical scenarios.
Further, it was seen that the correlation coefficients of the patient data were related to
this ratio. For example, as the ratio of activity within the reconstructed ROI to activity
outside the reconstructed ROI decreased, the correlation coefficients decreased. This is
shown in Table 4.1.
Table 4.1: Relationship between background activity and correlation coefficients
TOSEM vs NTOSEM
Correlation Coefficient

TMOSEM vs NTOSEM
Correlation Coefficient

Phantom

0.996

0.999

Reconstructed
ROI
/
Background
0.90

Clinical Scan #1

0.734

0.996

0.36

Clinical Scan #2

0.658

0.984

0.28

Count Ratio and Defect Size Analysis
Severe truncation led to large errors in count ratios between different heart
regions. Table 4.2 shows that these errors for clinical data were on average larger than
100% when reconstructing using TOSEM. Use of TMOSEM resulted in an average error
of 8.9%, which is a substantial improvement. A similar improvement was noted for the
phantom data. In the case of defect size analysis, severe truncation of data led to an
average error of 17% for the clinical data. This error was reduced to 0.19% when data
was reconstructed via TMOSEM (See Table 4.3).
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Table 4.2: Error between count ratios compared to gold standard (NTOSEM)
COUNT RATIO ANALYSIS

TOSEM
TMOSEM

Min.
Error
19.3%
1.7%

Clinical Data
Max.
Average
Error
Error
>100%
>100%
17.4%
8.9%

Phantom Data
Average Error
>100%
4.3%

Table 4.3: Percent error of defect size compared to gold standard (NTOSEM)
DEFECT SIZE ANALYSIS
Relative Difference

TOSEM
TMOSEM

Min.
Error
9.56%
0.0%

Clinical Data
Max.
Average
Error
Error
24.62%
17.13%
0.46%
0.19%

4.4 DISCUSSION
In this manuscript, we used the cross-talk concept to evaluate the tomographic
sampling characteristics of highly truncated SPECT. This analysis was independent of
reconstruction algorithm, and is fundamental to the geometry of data acquisition. Crosstalk analysis demonstrated that imaging with a small FOV gamma camera results in nonuniform sensitivity across the trans-axial plane. However, it is uniform within a small
ROI corresponding to the size of the gamma camera FOV. This was demonstrated in
figure 3A, where the sensitivity was at its highest level within the ROI and gradually
decreased away from the ROI. Also, it was observed that within the ROI the resolution
was isotropic, while it was highly anisotropic outside the FOV (figures 4.3B and 4.3C).
The aliasing is consistent with the gamma camera sampling pattern. Areas within the
ROI are always seen by the gamma camera, leading to circularly symmetric point spread
functions. However, areas outside the ROI are seen only during limited arcs as the
gamma camera rotates. Consequently, these areas featured elongated point spread
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functions along dimensions that were under sampled. As indicated in the methods
section, we used a simplified transition matrix to isolate the effects of imaging geometry.
In practice, the transition matrix ‘A’ is much more complex, being dependent upon the
physical effects such as the object scatter and attenuation, and the depth dependent
resolution effects for the collimator on the object being imaged. Future work could
explore the calculation of the crosstalk matrix using a Monte Carlo derived transition
matrix evaluating the effects of attenuation, scatter, and collimator response.
Using TOSEM resulted in the appearance of a hot rim artifact in the reconstructed
images, which is seen commonly when projections are truncated. This is because the
OSEM algorithm, in many implementations, constrains the radioactivity to remain within
the boundaries of the truncated projection data. The OSEM algorithm is programmed to
count all activity that is measured to be within the FOV of the camera causing the hot rim
artifact. The reconstruction method of equations 4.1 and 4.2 relax this constraint and use
the body contour information provided by the full FOV X-ray CT to effectively eliminate
artifacts within the reconstructed FOV. This was demonstrated in figures 4.4 and 4.5, the
scatter plot analysis for all patients, the count ratio analysis given in table 4.2 and the
infarct size analysis given in table 4.3, when using TMOSEM compared to NTOSEM. In
the case of the phantom study, the differences seen were not as great. This, we speculate,
is due to comparatively less background activity injected around the cardiac insert of the
torso phantom. With less activity in the area outside the reconstructed ROI, there is less
probability of image interference when analyzing the reconstructed ROI.

When

analyzing the relationship between the ratio of counts in the reconstructed ROI to counts
outside the reconstructed ROI and the correlation between TOSEM vs NTOSEM, we
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discovered that the said count ratio decreased as the correlation decreased. In other
words, the performance of the conventional OSEM algorithm deteriorated. Note that the
performance of the modified OSEM algorithm, TMOSEM, also deteriorated, but not to
the same extent.

It is important to note that there is no standard method for

compensating for truncation in clinical systems, and manufacturers may take differing
approaches [1]. For the sake of clarity here, we delineate explicitly the method of
equations 4.1 and 4.2, which is simple to implement and extremely flexible in dealing
with complex gamma camera orbits.
When simulating acquisitions by a 16x16 cm FOV gamma camera, and
comparing the ratio of counts within the heart and the change in defect size, the average
errors using TMOSEM compared to NTOSEM were 8.9% and 0.19% respectively in our
patient population. The difference in defect size comparing TMOSEM and NTOSEM
was less than 1%. The errors when comparing count ratios are significantly less when
using TMOSEM as opposed to TOSEM; however, a maximum error of 17.4% is high for
many applications. Future work could focus on better understanding the impact of
TMOSEM outside the FOV and the role scattered activity originating outside of the FOV
contribute information inside the reconstructed FOV. Also, the optimization of the
number of subsets and iterations of the modified OSEM could be studied. Future
experiments could also focus on better understanding of how background noise will
effect the reconstruction and the effect of the location and size of the ROI in the
reconstruction.
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4.5 CONCLUSION
The topic of truncation and its management has always been important, and will
likely grow with the potential benefits of solid state detectors which may decrease the
size of gamma detectors, the increase in imaging of larger patients, using converging
geometries in collimation, and the need of hotspot imaging to follow radio-labeled
transplanted cells.

In this work we have demonstrated that significantly truncated

SPECT data compromises tomographic sampling, yielding non-uniform sensitivity and a
non-stationary anisotropic resolution. However, we also demonstrated in phantom and
clinical cardiac data that within a small region that is sampled adequately, the truncated
data can be largely restored back to its original non-truncated form via a simple
modification to the OS-EM algorithm when non-truncated CT is available.
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CHAPTER 5:

CONCLUSIONS

5.1 Summary of Results
An important goal in myocardial stem cell therapy is the development of tools to
determine the location of transplanted stem cells and assess their viability. This thesis
demonstrated that a form of medical imaging technology – SPECT/CT – has the potential
to achieve this goal. Three aspects of SPECT/CT application to monitoring cardiac stem
cell therapy were evaluated: comparing two popular models of SPECT/CT systems,
evaluating use of contrast-enhanced CT in SPECT/CT to improve transplanted stem cell
localization, and exploring the potential for small field-of-view gamma cameras in
SPECT/CT.
There are currently two popular SPECT/CT systems that are commercially
available. One incorporates a slow rotation CT (GE Infinia/Hawkeye-4), while the other
incorporates a fast rotation CT (Siemens Symbia/T6). To date there have been no
publications comparing the two systems for attenuation correction in cardiac SPECT
perfusion imaging, and therefore indicating which SPECT/CT system would be better
suited for imaging cells. Our computer simulations showed an improvement in RMS
error comparing SPECT cardiac polar plots using a fast rotation CT attenuation map as
opposed to a slow rotation CT attenuation map. Canine experiments also showed an
advantage of using a fast rotation CT. Improvements in RMS error and correlation
coefficient were recorded for all canines when analyzing a central trans-axial slice of the
heart when using a fast rotation CT attenuation map.
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An important aspect of monitoring cardiac stem cell therapy is determining the
location of transplanted cells relative to the region of reduced blood flow. To this end,
we developed a technique combining SPECT with cardiac gated first-pass perfusion CT,
which is only possible when using a fast rotation CT, and evaluated it in a canine model
of heart disease. Our technique was capable of localizing the transplanted cells in
relation to the region of reduced blood flow. In addition, viability is also important in
imaging transplanted cells, but before viability can be assessed, the period of time that
cells can be followed had to be determined. A CNR analysis was performed on the
SPECT/CT system and results showed that cells can be followed for up to a period of 22
days if the location of the cells is known, which is possible with the fused first-pass
perfusion CT and SPECT imaging technique. To image cells for an even longer period
of time post-transplantation, improvements to the sensitivity of gamma camera imaging
systems would be required. Such an improvement might be achieved via solid-state
detector technology.
Several groups and manufacturers have begun to explore a “next generation” of
gamma cameras wherein the scintillation crystal and photomultiplier tube combination is
replaced with a solid-state semiconductor detector. One challenge to the implementation
of solid-state detectors is their very high cost. For cardiac imaging, these high costs
might be lessened by using small detectors that are sufficient in size to image the heart.
However, in this scenario, the presence of radioactivity outside the heart introduces
artifacts into the reconstructed SPECT images that compromise quantification. In the
case of cardiac imaging, we demonstrated that imaging with a small field-of-view
detector can introduce errors in relative quantification in the heart of over 100%. We
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introduced a new reconstruction algorithm that substantially reduced these artifacts and
reduced errors to less than 10%.

5.2 Future Work
As this field is still fairly new, there are many interesting avenues to investigate.
To begin, the NCAT phantom in Chapter 2 can be manipulated to simulate both male and
female anatomies in addition to different body types (from very thin to very obese).
Currently, only the male anatomy in a standard body type was employed by us.
Repeating our investigations using the female anatomy and more body types may further
generalize our results in comparing slow and fast CT attenuation maps in SPECT. In
addition to body type, the NCAT phantom can include cardiac motion which was not
modeled in the current experiments. Regarding the canine imaging aspect: it might be
beneficial to compare more SPECT/CT systems such as the design introduced by
Phillips.
For the experiments in chapter 3, a standardized delivery system using an
automated power injector, rather than hand-injection for the contrast agent will help in
the ability to better quantify the results obtained from the first-pass perfusion CT
imaging. Currently, these results are qualitative, but if the delivery system can be
standardized allowing the same rate of injection for all studies, then perhaps the results
can be made more quantitative, and may be used to measure the therapeutic effects of the
transplanted cells.

The objective of this chapter was to introduce a new imaging

technique and show its feasibility on clinical equipment (albeit with a pre-clinical large
animal model of heart disease). Since we demonstrated the technique can localize
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transplanted cells in relation to an underlying infarct, its role could be expanded to
evaluate the efficacy of different cell transplant locations for stem cell therapy.
A final direction that this project may take is to combine the techniques
developed in this thesis into a single study. Specifically: a study using a solid-state small
field-of-view detector SPECT scanner coupled with a fast rotation CT to acquire firstpass perfusion CT may prove to be the best combination for imaging transplanted
myocardial stem cells.

The solid-state detector should improve SPECT counting

statistics and scatter correction to image the transplanted cells for a longer period of time.
Combining this with the localization aspect of the first-pass perfusion CT images could
make this an interesting and powerful platform for cell tracking.
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